{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:37:25Z","timestamp":1793194645045,"version":"4.5.0"},"reference-count":334,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41582-026-01262-3","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:13:54Z","timestamp":1790687634000},"page":"712-730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lysosomal dysfunction in neurodegenerative disease"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5674-3124","authenticated-orcid":false,"given":"Sarah M.","family":"Brooker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Coukos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4716-1886","authenticated-orcid":false,"given":"Dimitri","family":"Krainc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"1262_CR1","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41580-024-00757-5","volume":"25","author":"RA Nixon","year":"2024","unstructured":"Nixon, R. A. & Rubinsztein, D. C. Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases. Nat. Rev. Mol. Cell Biol. 25, 926\u2013946 https:\/\/doi.org\/10.1038\/s41580-024-00757-5 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1262_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.tins.2021.12.004","volume":"45","author":"V Udayar","year":"2022","unstructured":"Udayar, V., Chen, Y., Sidransky, E. & Jagasia, R. Lysosomal dysfunction in neurodegeneration: emerging concepts and methods. Trends Neurosci. 45, 184\u2013199 https:\/\/doi.org\/10.1016\/j.tins.2021.12.004 (2022).","journal-title":"Trends Neurosci."},{"key":"1262_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/mds.27614","volume":"34","author":"S Bandres-Ciga","year":"2019","unstructured":"Bandres-Ciga, S. et al. The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson\u2019s disease. Mov. Disord. 34, 460\u2013468 https:\/\/doi.org\/10.1002\/mds.27614 (2019).","journal-title":"Mov. Disord."},{"key":"1262_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat, C., Nalls, M. A. & Singleton, A. B. The genetic architecture of Parkinson\u2019s disease. Lancet Neurol. 19, 170\u2013178 https:\/\/doi.org\/10.1016\/S1474-4422(19)30287-X (2020).","journal-title":"Lancet Neurol."},{"key":"1262_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105360","volume":"154","author":"J Root","year":"2021","unstructured":"Root, J., Merino, P., Nuckols, A., Johnson, M. & Kukar, T. Lysosome dysfunction as a cause of neurodegenerative diseases: lessons from frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol. Dis. 154 105360 https:\/\/doi.org\/10.1016\/j.nbd.2021.105360 (2021).","journal-title":"Neurobiol. Dis."},{"key":"1262_CR6","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1093\/brain\/awx285","volume":"140","author":"LA Robak","year":"2017","unstructured":"Robak, L. A. et al. Excessive burden of lysosomal storage disorder gene variants in Parkinson\u2019s disease. Brain 140, 3191\u20133203 https:\/\/doi.org\/10.1093\/brain\/awx285 (2017).","journal-title":"Brain"},{"key":"1262_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah5642","volume":"9","author":"ME Ward","year":"2017","unstructured":"Ward, M. E. et al. Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis. Sci. Transl. Med. 9, eaah5642 https:\/\/doi.org\/10.1126\/scitranslmed.aah5642 (2017).","journal-title":"Sci. Transl. Med."},{"key":"1262_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70206","volume":"32","author":"F Feo","year":"2025","unstructured":"Feo, F. et al. High prevalence of GALC gene variants in adults with neurodegenerative conditions. Eur. J. Neurol. 32, e70206 https:\/\/doi.org\/10.1111\/ene.70206 (2025).","journal-title":"Eur. J. Neurol."},{"key":"1262_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrm2217","volume":"8","author":"JP Luzio","year":"2007","unstructured":"Luzio, J. P., Pryor, P. R. & Bright, N. A. Lysosomes: fusion and function. Nat. Rev. Mol. Cell Biol. 8, 622\u2013632 https:\/\/doi.org\/10.1038\/nrm2217 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1262_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-015-0041-1","volume":"4","author":"YB Hu","year":"2015","unstructured":"Hu, Y. B., Dammer, E. B., Ren, R. J. & Wang, G. The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration. Transl. Neurodegener. 4, 18 https:\/\/doi.org\/10.1186\/s40035-015-0041-1 (2015).","journal-title":"Transl. Neurodegener."},{"key":"1262_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo, M., Raposo, G. & Thery, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30, 255\u2013289 https:\/\/doi.org\/10.1146\/annurev-cellbio-101512-122326 (2014).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"1262_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41580-023-00676-x","volume":"25","author":"C Settembre","year":"2024","unstructured":"Settembre, C. & Perera, R. M. Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology. Nat. Rev. Mol. Cell Biol. 25, 223\u2013245 https:\/\/doi.org\/10.1038\/s41580-023-00676-x (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1262_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2019.08.050","volume":"179","author":"YC Liao","year":"2019","unstructured":"Liao, Y. C. et al. RNA granules hitchhike on lysosomes for long-distance transport, using annexin A11 as a molecular tether. Cell 179, 147\u2013164.e20 https:\/\/doi.org\/10.1016\/j.cell.2019.08.050 (2019).","journal-title":"Cell"},{"key":"1262_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc7209","volume":"6","author":"M Lu","year":"2020","unstructured":"Lu, M. et al. The structure and global distribution of the endoplasmic reticulum network are actively regulated by lysosomes. Sci. Adv. 6, eabc7209 https:\/\/doi.org\/10.1126\/sciadv.abc7209 (2020).","journal-title":"Sci. Adv."},{"key":"1262_CR15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. \u03b1-Synuclein in Lewy bodies. Nature 388, 839\u2013840 https:\/\/doi.org\/10.1038\/42166 (1997).","journal-title":"Nature"},{"key":"1262_CR16","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 https:\/\/doi.org\/10.1016\/S1474-4422(19)30320-5 (2019).","journal-title":"Lancet Neurol."},{"key":"1262_CR17","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1093\/brain\/awae142","volume":"147","author":"L Cook","year":"2024","unstructured":"Cook, L. et al. Parkinson\u2019s disease variant detection and disclosure: PD GENEration, a North American study. Brain 147, 2668\u20132679 https:\/\/doi.org\/10.1093\/brain\/awae142 (2024).","journal-title":"Brain"},{"key":"1262_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41588-023-01584-8","volume":"56","author":"JJ Kim","year":"2024","unstructured":"Kim, J. J. et al. Multi-ancestry genome-wide association meta-analysis of Parkinson\u2019s disease. Nat. Genet. 56, 27\u201336 https:\/\/doi.org\/10.1038\/s41588-023-01584-8 (2024).","journal-title":"Nat. Genet."},{"key":"1262_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/genes15121605","volume":"15","author":"C Koros","year":"2024","unstructured":"Koros, C. et al. A global perspective of GBA1-related Parkinson\u2019s disease: a narrative review. Genes 15, 1605 https:\/\/doi.org\/10.3390\/genes15121605 (2024).","journal-title":"Genes"},{"key":"1262_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0336-2","volume":"14","author":"J Do","year":"2019","unstructured":"Do, J., McKinney, C., Sharma, P. & Sidransky, E. Glucocerebrosidase and its relevance to Parkinson disease. Mol. Neurodegener. 14, 36 https:\/\/doi.org\/10.1186\/s13024-019-0336-2 (2019).","journal-title":"Mol. Neurodegener."},{"key":"1262_CR21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/jmg.2004.024455","volume":"41","author":"O Goker-Alpan","year":"2004","unstructured":"Goker-Alpan, O. et al. Parkinsonism among Gaucher disease carriers. J. Med. Genet. 41, 937\u2013940 https:\/\/doi.org\/10.1136\/jmg.2004.024455 (2004).","journal-title":"J. Med. Genet."},{"key":"1262_CR22","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky, E. et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N. Engl. J. Med. 361, 1651\u20131661 https:\/\/doi.org\/10.1056\/NEJMoa0901281 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1262_CR23","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/brain\/awac413","volume":"146","author":"K Senkevich","year":"2023","unstructured":"Senkevich, K. et al. GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson\u2019s disease. Brain 146, 1859\u20131872 https:\/\/doi.org\/10.1093\/brain\/awac413 (2023).","journal-title":"Brain"},{"key":"1262_CR24","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","volume":"90","author":"KR Smith","year":"2012","unstructured":"Smith, K. R. et al. Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am. J. Hum. Genet. 90, 1102\u20131107 https:\/\/doi.org\/10.1016\/j.ajhg.2012.04.021 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"1262_CR25","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s12035-016-9698-4","volume":"54","author":"HM Xu","year":"2017","unstructured":"Xu, H. M. et al. PGRN is associated with late-onset Alzheimer\u2019s disease: a case\u2013control replication study and meta-analysis. Mol. Neurobiol. 54, 1187\u20131195 https:\/\/doi.org\/10.1007\/s12035-016-9698-4 (2017).","journal-title":"Mol. Neurobiol."},{"key":"1262_CR26","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/jmg-2023-109219","volume":"61","author":"D Lopergolo","year":"2024","unstructured":"Lopergolo, D. et al. Familial Alzheimer\u2019s disease associated with heterozygous NPC1 mutation. J. Med. Genet. 61, 332\u2013339 https:\/\/doi.org\/10.1136\/jmg-2023-109219 (2024).","journal-title":"J. Med. Genet."},{"key":"1262_CR27","doi-asserted-by":"publisher","first-page":"8332","DOI":"10.1073\/pnas.0903223106","volume":"106","author":"K Ohmi","year":"2009","unstructured":"Ohmi, K. et al. Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy. Proc. Natl Acad. Sci. USA 106, 8332\u20138337 https:\/\/doi.org\/10.1073\/pnas.0903223106 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"JR Mazzulli","year":"2011","unstructured":"Mazzulli, J. R. et al. Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146, 37\u201352 https:\/\/doi.org\/10.1016\/j.cell.2011.06.001 (2011).","journal-title":"Cell"},{"key":"1262_CR29","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/brain\/awt367","volume":"137","author":"KE Murphy","year":"2014","unstructured":"Murphy, K. E. et al. Reduced glucocerebrosidase is associated with increased \u03b1-synuclein in sporadic Parkinson\u2019s disease. Brain 137, 834\u2013848 https:\/\/doi.org\/10.1093\/brain\/awt367 (2014).","journal-title":"Brain"},{"key":"1262_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.nbd.2018.09.015","volume":"121","author":"AL Gundner","year":"2019","unstructured":"Gundner, A. L. et al. Path mediation analysis reveals GBA impacts Lewy body disease status by increasing \u03b1-synuclein levels. Neurobiol. Dis. 121, 205\u2013213 https:\/\/doi.org\/10.1016\/j.nbd.2018.09.015 (2019).","journal-title":"Neurobiol. Dis."},{"key":"1262_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ana.23614","volume":"72","author":"ME Gegg","year":"2012","unstructured":"Gegg, M. E. et al. Glucocerebrosidase deficiency in substantia nigra of Parkinson disease brains. Ann. Neurol. 72, 455\u2013463 https:\/\/doi.org\/10.1002\/ana.23614 (2012).","journal-title":"Ann. Neurol."},{"key":"1262_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-020-00712-3","volume":"14","author":"R Thomas","year":"2021","unstructured":"Thomas, R., Moloney, E. B., Macbain, Z. K., Hallett, P. J. & Isacson, O. Fibroblasts from idiopathic Parkinson\u2019s disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2. Mol. Brain 14, 16 https:\/\/doi.org\/10.1186\/s13041-020-00712-3 (2021).","journal-title":"Mol. Brain"},{"key":"1262_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau6870","volume":"11","author":"LF Burbulla","year":"2019","unstructured":"Burbulla, L. F. et al. A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson\u2019s disease. Sci. Transl. Med. 11, eaau6870 https:\/\/doi.org\/10.1126\/scitranslmed.aau6870 (2019).","journal-title":"Sci. Transl. Med."},{"key":"1262_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106039","volume":"122","author":"G Maayan Eshed","year":"2024","unstructured":"Maayan Eshed, G. & Alcalay, R. N. GBA1- and LRRK2-directed treatments: the way forward. Parkinsonism Relat. Disord. 122, 106039 https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106039 (2024).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1262_CR35","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla, L. F. et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science 357, 1255\u20131261 https:\/\/doi.org\/10.1126\/science.aam9080 (2017).","journal-title":"Science"},{"key":"1262_CR36","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1002\/mds.30006","volume":"39","author":"SRL Vieira","year":"2024","unstructured":"Vieira, S. R. L. et al. Consensus guidance for genetic counseling in GBA1 variants: a focus on Parkinson\u2019s disease. Mov. Disord. 39, 2144\u20132154 https:\/\/doi.org\/10.1002\/mds.30006 (2024).","journal-title":"Mov. Disord."},{"key":"1262_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1212\/WNL.0b013e318245f476","volume":"78","author":"M Anheim","year":"2012","unstructured":"Anheim, M. et al. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology 78, 417\u2013420 https:\/\/doi.org\/10.1212\/WNL.0b013e318245f476 (2012).","journal-title":"Neurology"},{"key":"1262_CR38","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1001\/jamaneurol.2014.313","volume":"71","author":"RN Alcalay","year":"2014","unstructured":"Alcalay, R. N. et al. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes. JAMA Neurol. 71, 752\u2013757 https:\/\/doi.org\/10.1001\/jamaneurol.2014.313 (2014).","journal-title":"JAMA Neurol."},{"key":"1262_CR39","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1002\/mds.28200","volume":"35","author":"R Balestrino","year":"2020","unstructured":"Balestrino, R. et al. Penetrance of glucocerebrosidase (GBA) mutations in Parkinson\u2019s disease: a kin cohort study. Mov. Disord. 35, 2111\u20132114 https:\/\/doi.org\/10.1002\/mds.28200 (2020).","journal-title":"Mov. Disord."},{"key":"1262_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/npjparkd.2016.4","volume":"2","author":"RN Alcalay","year":"2016","unstructured":"Alcalay, R. N. et al. SCARB2 variants and glucocerebrosidase activity in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2, 16004 https:\/\/doi.org\/10.1038\/npjparkd.2016.4 (2016).","journal-title":"NPJ Parkinsons Dis."},{"key":"1262_CR41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/brain\/awz350","volume":"143","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat, C. et al. Genetic modifiers of risk and age at onset in GBA associated Parkinson\u2019s disease and Lewy body dementia. Brain 143 234\u2013248 https:\/\/doi.org\/10.1093\/brain\/awz350 (2020).","journal-title":"Brain"},{"key":"1262_CR42","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1093\/hmg\/ddac047","volume":"31","author":"MJ Kim","year":"2022","unstructured":"Kim, M. J., Jeong, H. & Krainc, D. Lysosomal ceramides regulate cathepsin B-mediated processing of saposin C and glucocerebrosidase activity. Hum. Mol. Genet. 31, 2424\u20132437 https:\/\/doi.org\/10.1093\/hmg\/ddac047 (2022).","journal-title":"Hum. Mol. Genet."},{"key":"1262_CR43","doi-asserted-by":"publisher","first-page":"11560","DOI":"10.1007\/s12035-025-04996-1","volume":"62","author":"EN Somerville","year":"2025","unstructured":"Somerville, E. N. et al. Genome-wide association study of glucocerebrosidase activity modifiers. Mol. Neurobiol. 62, 11560\u201311571 https:\/\/doi.org\/10.1007\/s12035-025-04996-1 (2025).","journal-title":"Mol. Neurobiol."},{"key":"1262_CR44","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1126\/science.adq6650","volume":"388","author":"G Minakaki","year":"2025","unstructured":"Minakaki, G. et al. Commander complex regulates lysosomal function and is implicated in Parkinson\u2019s disease risk. Science 388, 204\u2013211 https:\/\/doi.org\/10.1126\/science.adq6650 (2025).","journal-title":"Science"},{"key":"1262_CR45","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1474-4422(26)00090-6","volume":"25","author":"E Menozzi","year":"2026","unstructured":"Menozzi, E. et al. New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson\u2019s disease: prospects for treatment. Lancet Neurol. 25, 602\u2013614 https:\/\/doi.org\/10.1016\/S1474-4422(26)00090-6 (2026).","journal-title":"Lancet Neurol."},{"key":"1262_CR46","doi-asserted-by":"publisher","first-page":"23542","DOI":"10.1074\/jbc.M801992200","volume":"283","author":"T Vogiatzi","year":"2008","unstructured":"Vogiatzi, T., Xilouri, M., Vekrellis, K. & Stefanis, L. Wild type \u03b1-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J. Biol. Chem. 283, 23542\u201323556 https:\/\/doi.org\/10.1074\/jbc.M801992200 (2008).","journal-title":"J. Biol. Chem."},{"key":"1262_CR47","doi-asserted-by":"publisher","first-page":"25009","DOI":"10.1074\/jbc.M300227200","volume":"278","author":"JL Webb","year":"2003","unstructured":"Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N. & Rubinsztein, D. C. \u03b1-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278, 25009\u201325013 https:\/\/doi.org\/10.1074\/jbc.M300227200 (2003).","journal-title":"J. Biol. Chem."},{"key":"1262_CR48","doi-asserted-by":"publisher","first-page":"9678","DOI":"10.1021\/bi800699v","volume":"47","author":"D Sevlever","year":"2008","unstructured":"Sevlever, D., Jiang, P. & Yen, S. H. Cathepsin D is the main lysosomal enzyme involved in the degradation of \u03b1-synuclein and generation of its carboxy-terminally truncated species. Biochemistry 47, 9678\u20139687 https:\/\/doi.org\/10.1021\/bi800699v (2008).","journal-title":"Biochemistry"},{"key":"1262_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.581805","volume":"9","author":"J Bunk","year":"2021","unstructured":"Bunk, J. et al. Cathepsin D variants associated with neurodegenerative diseases show dysregulated functionality and modified \u03b1-synuclein degradation properties. Front. Cell Dev. Biol. 9, 581805 https:\/\/doi.org\/10.3389\/fcell.2021.581805 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1262_CR50","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.neurobiolaging.2009.10.011","volume":"32","author":"M Schuur","year":"2011","unstructured":"Schuur, M. et al. Cathepsin D gene and the risk of Alzheimer\u2019s disease: a population-based study and meta-analysis. Neurobiol. Aging 32, 1607\u20131614 https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.10.011 (2011).","journal-title":"Neurobiol. Aging"},{"key":"1262_CR51","doi-asserted-by":"publisher","first-page":"9322","DOI":"10.1073\/pnas.1500937112","volume":"112","author":"RP McGlinchey","year":"2015","unstructured":"McGlinchey, R. P. & Lee, J. C. Cysteine cathepsins are essential in lysosomal degradation of \u03b1-synuclein. Proc. Natl Acad. Sci. USA 112, 9322\u20139327 https:\/\/doi.org\/10.1073\/pnas.1500937112 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-024-00779-9","volume":"19","author":"J Jones-Tabah","year":"2024","unstructured":"Jones-Tabah, J. et al. The Parkinson\u2019s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons. Mol. Neurodegener. 19, 88 https:\/\/doi.org\/10.1186\/s13024-024-00779-9 (2024).","journal-title":"Mol. Neurodegener."},{"key":"1262_CR53","doi-asserted-by":"publisher","first-page":"14241","DOI":"10.1074\/jbc.RA119.008733","volume":"294","author":"J Gao","year":"2019","unstructured":"Gao, J., Perera, G., Bhadbhade, M., Halliday, G. M. & Dzamko, N. Autophagy activation promotes clearance of \u03b1-synuclein inclusions in fibril-seeded human neural cells. J. Biol. Chem. 294, 14241\u201314256 https:\/\/doi.org\/10.1074\/jbc.RA119.008733 (2019).","journal-title":"J. Biol. Chem."},{"key":"1262_CR54","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T. & Sulzer, D. Impaired degradation of mutant \u03b1-synuclein by chaperone-mediated autophagy. Science 305, 1292\u20131295 https:\/\/doi.org\/10.1126\/science.1101738 (2004).","journal-title":"Science"},{"key":"1262_CR55","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/ncb3114","volume":"17","author":"DL Medina","year":"2015","unstructured":"Medina, D. L. et al. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat. Cell Biol. 17, 288\u2013299 https:\/\/doi.org\/10.1038\/ncb3114 (2015).","journal-title":"Nat. Cell Biol."},{"key":"1262_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.861202","volume":"16","author":"MR Pollmanns","year":"2022","unstructured":"Pollmanns, M. R. et al. Activated endolysosomal cation channel TRPML1 facilitates maturation of \u03b1-synuclein-containing autophagosomes. Front. Cell Neurosci. 16, 861202 https:\/\/doi.org\/10.3389\/fncel.2022.861202 (2022).","journal-title":"Front. Cell Neurosci."},{"key":"1262_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2026.118951","volume":"315","author":"M Czuba","year":"2026","unstructured":"Czuba, M., Szafranska, K., Kolaczkowski, M. & Marcinkowska, M. Targeting lysosomal dysfunction with small-molecule TRPML1 ligands: therapeutic opportunities in lysosomal storage disorders, neurodegeneration and beyond. Eur. J. Med. Chem. 315, 118951 https:\/\/doi.org\/10.1016\/j.ejmech.2026.118951 (2026).","journal-title":"Eur. J. Med. Chem."},{"key":"1262_CR58","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S1474-4422(24)00378-8","volume":"23","author":"SY Lim","year":"2024","unstructured":"Lim, S. Y. et al. Uncovering the genetic basis of Parkinson\u2019s disease globally: from discoveries to the clinic. Lancet Neurol. 23, 1267\u20131280 https:\/\/doi.org\/10.1016\/S1474-4422(24)00378-8 (2024).","journal-title":"Lancet Neurol."},{"key":"1262_CR59","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy, D. G. et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol. 7, 583\u2013590 https:\/\/doi.org\/10.1016\/S1474-4422(08)70117-0 (2008).","journal-title":"Lancet Neurol."},{"key":"1262_CR60","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/acn3.51776","volume":"10","author":"YL Sosero","year":"2023","unstructured":"Sosero, Y. L. & Gan-Or, Z. LRRK2 and Parkinson\u2019s disease: from genetics to targeted therapy. Ann. Clin. Transl. Neurol. 10, 850\u2013864 https:\/\/doi.org\/10.1002\/acn3.51776 (2023).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1262_CR61","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/mds.27059","volume":"32","author":"AJ Lee","year":"2017","unstructured":"Lee, A. J. et al. Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry. Mov. Disord. 32, 1432\u20131438 https:\/\/doi.org\/10.1002\/mds.27059 (2017).","journal-title":"Mov. Disord."},{"key":"1262_CR62","doi-asserted-by":"publisher","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West, A. B. et al. Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl Acad. Sci. USA 102, 16842\u201316847 https:\/\/doi.org\/10.1073\/pnas.0507360102 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR63","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar5429","volume":"10","author":"R Di Maio","year":"2018","unstructured":"Di Maio, R. et al. LRRK2 activation in idiopathic Parkinson\u2019s disease. Sci. Transl. Med. 10, eaar5429 https:\/\/doi.org\/10.1126\/scitranslmed.aar5429 (2018).","journal-title":"Sci. Transl. Med."},{"key":"1262_CR64","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1073\/pnas.1717590115","volume":"115","author":"M Nguyen","year":"2018","unstructured":"Nguyen, M. & Krainc, D. LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson\u2019s disease. Proc. Natl Acad. Sci. USA 115, 5576\u20135581 https:\/\/doi.org\/10.1073\/pnas.1717590115 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR65","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ceb.2020.01.001","volume":"63","author":"M Taylor","year":"2020","unstructured":"Taylor, M. & Alessi, D. R. Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson\u2019s disease. Curr. Opin. Cell Biol. 63, 102\u2013113 https:\/\/doi.org\/10.1016\/j.ceb.2020.01.001 (2020).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1262_CR66","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1007\/s12035-021-02327-8","volume":"58","author":"L Streubel-Gallasch","year":"2021","unstructured":"Streubel-Gallasch, L. et al. Parkinson\u2019s disease-associated LRRK2 interferes with astrocyte-mediated alpha-synuclein clearance. Mol. Neurobiol. 58, 3119\u20133140 https:\/\/doi.org\/10.1007\/s12035-021-02327-8 (2021).","journal-title":"Mol. Neurobiol."},{"key":"1262_CR67","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nbd.2017.12.005","volume":"111","author":"J Schapansky","year":"2018","unstructured":"Schapansky, J. et al. Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble \u03b1-synuclein in neurons. Neurobiol. Dis. 111, 26\u201335 https:\/\/doi.org\/10.1016\/j.nbd.2017.12.005 (2018).","journal-title":"Neurobiol. Dis."},{"key":"1262_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00442","volume":"14","author":"A Sanyal","year":"2020","unstructured":"Sanyal, A., Novis, H. S., Gasser, E., Lin, S. & LaVoie, M. J. LRRK2 kinase inhibition rescues deficits in lysosome function due to heterozygous GBA1 expression in human iPSC-derived neurons. Front. Neurosci. 14, 442 https:\/\/doi.org\/10.3389\/fnins.2020.00442 (2020).","journal-title":"Front. Neurosci."},{"key":"1262_CR69","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1093\/hmg\/ddv314","volume":"24","author":"AG Henry","year":"2015","unstructured":"Henry, A. G. et al. Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression. Hum. Mol. Genet. 24, 6013\u20136028 https:\/\/doi.org\/10.1093\/hmg\/ddv314 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"1262_CR70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303789120","volume":"120","author":"N Yadavalli","year":"2023","unstructured":"Yadavalli, N. & Ferguson, S. M. LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition. Proc. Natl Acad. Sci. USA 120, e2303789120 https:\/\/doi.org\/10.1073\/pnas.2303789120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2024.102841","volume":"85","author":"SM Brooker","year":"2024","unstructured":"Brooker, S. M., Naylor, G. E. & Krainc, D. Cell biology of Parkinson\u2019s disease: mechanisms of synaptic, lysosomal, and mitochondrial dysfunction. Curr. Opin. Neurobiol. 85, 102841 https:\/\/doi.org\/10.1016\/j.conb.2024.102841 (2024).","journal-title":"Curr. Opin. Neurobiol."},{"key":"1262_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13413-w","volume":"10","author":"D Ysselstein","year":"2019","unstructured":"Ysselstein, D. et al. LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson\u2019s disease patients. Nat. Commun. 10, 5570 https:\/\/doi.org\/10.1038\/s41467-019-13413-w (2019).","journal-title":"Nat. Commun."},{"key":"1262_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00354-3","volume":"8","author":"M Kedariti","year":"2022","unstructured":"Kedariti, M. et al. LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 92 https:\/\/doi.org\/10.1038\/s41531-022-00354-3 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1262_CR74","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.12813","volume":"5","author":"M Steger","year":"2016","unstructured":"Steger, M. et al. Phosphoproteomics reveals that Parkinson\u2019s disease kinase LRRK2 regulates a subset of Rab GTPases. eLife 5, e12813 https:\/\/doi.org\/10.7554\/eLife.12813 (2016).","journal-title":"eLife"},{"key":"1262_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2025.102482","volume":"93","author":"A Bentley-DeSousa","year":"2025","unstructured":"Bentley-DeSousa, A., Clegg, D. & Ferguson, S. M. LRRK2, lysosome damage, and Parkinson\u2019s disease. Curr. Opin. Cell Biol. 93, 102482 https:\/\/doi.org\/10.1016\/j.ceb.2025.102482 (2025).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1262_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb2454","volume":"6","author":"L Bonet-Ponce","year":"2020","unstructured":"Bonet-Ponce, L. et al. LRRK2 mediates tubulation and vesicle sorting from lysosomes. Sci. Adv. 6, eabb2454 https:\/\/doi.org\/10.1126\/sciadv.abb2454 (2020).","journal-title":"Sci. Adv."},{"key":"1262_CR77","doi-asserted-by":"publisher","first-page":"E9115","DOI":"10.1073\/pnas.1812196115","volume":"115","author":"T Eguchi","year":"2018","unstructured":"Eguchi, T. et al. LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis. Proc. Natl Acad. Sci. USA 115, E9115\u2013E9124 https:\/\/doi.org\/10.1073\/pnas.1812196115 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105081","volume":"145","author":"T Kuwahara","year":"2020","unstructured":"Kuwahara, T. et al. Roles of lysosomotropic agents on LRRK2 activation and Rab10 phosphorylation. Neurobiol. Dis. 145, 105081 https:\/\/doi.org\/10.1016\/j.nbd.2020.105081 (2020).","journal-title":"Neurobiol. Dis."},{"key":"1262_CR79","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.87255","volume":"12","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes. eLife 12, e87255 https:\/\/doi.org\/10.7554\/eLife.87255 (2023).","journal-title":"eLife"},{"key":"1262_CR80","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.87098","volume":"12","author":"HS Dhekne","year":"2023","unstructured":"Dhekne, H. S. et al. Genome-wide screen reveals Rab12 GTPase as a critical activator of Parkinson\u2019s disease-linked LRRK2 kinase. eLife 12, e87098 https:\/\/doi.org\/10.7554\/eLife.87098 (2023).","journal-title":"eLife"},{"key":"1262_CR81","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.79771","volume":"11","author":"EG Vides","year":"2022","unstructured":"Vides, E. G. et al. A feed-forward pathway drives LRRK2 kinase membrane recruitment and activation. eLife 11, e79771 https:\/\/doi.org\/10.7554\/eLife.79771 (2022).","journal-title":"eLife"},{"key":"1262_CR82","doi-asserted-by":"publisher","unstructured":"Clegg, D., Bentley-DeSousa, A., Roczniak-Ferguson, A. & Ferguson, S. M. LRRK2 integrates Rab and GABARAP interactions to sense and respond to distinct lysosomal stresses. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.11.19.689251 (2025).","DOI":"10.1101\/2025.11.19.689251"},{"key":"1262_CR83","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1080\/15548627.2024.2330032","volume":"20","author":"T Kuwahara","year":"2024","unstructured":"Kuwahara, T. & Iwatsubo, T. CASM mediates LRRK2 recruitment and activation under lysosomal stress. Autophagy 20, 1692\u20131693 https:\/\/doi.org\/10.1080\/15548627.2024.2330032 (2024).","journal-title":"Autophagy"},{"key":"1262_CR84","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202310150","volume":"224","author":"A Bentley-DeSousa","year":"2025","unstructured":"Bentley-DeSousa, A., Roczniak-Ferguson, A. & Ferguson, S. M. A STING\u2013CASM\u2013GABARAP pathway activates LRRK2 at lysosomes. J. Cell Biol. 224, e202310150 https:\/\/doi.org\/10.1083\/jcb.202310150 (2025).","journal-title":"J. Cell Biol."},{"key":"1262_CR85","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020104494","volume":"39","author":"S Herbst","year":"2020","unstructured":"Herbst, S. et al. LRRK2 activation controls the repair of damaged endomembranes in macrophages. EMBO J. 39, e104494 https:\/\/doi.org\/10.15252\/embj.2020104494 (2020).","journal-title":"EMBO J."},{"key":"1262_CR86","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202404018","volume":"224","author":"L Bonet-Ponce","year":"2025","unstructured":"Bonet-Ponce, L. et al. JIP4 and RILPL1 utilize opposing motor force to dynamically regulate lysosomal tubulation. J. Cell Biol. 224, e202404018 https:\/\/doi.org\/10.1083\/jcb.202404018 (2025).","journal-title":"J. Cell Biol."},{"key":"1262_CR87","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1093\/hmg\/ddp346","volume":"18","author":"J Alegre-Abarrategui","year":"2009","unstructured":"Alegre-Abarrategui, J. et al. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum. Mol. Genet. 18, 4022\u20134034 https:\/\/doi.org\/10.1093\/hmg\/ddp346 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"1262_CR88","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1016\/j.bbamcr.2013.07.020","volume":"1833","author":"C Manzoni","year":"2013","unstructured":"Manzoni, C. et al. Inhibition of LRRK2 kinase activity stimulates macroautophagy. Biochim. Biophys. Acta Mol. Cell Res. 1833, 2900\u20132910 https:\/\/doi.org\/10.1016\/j.bbamcr.2013.07.020 (2013).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"1262_CR89","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","volume":"32","author":"MS Moehle","year":"2012","unstructured":"Moehle, M. S. et al. LRRK2 inhibition attenuates microglial inflammatory responses. J. Neurosci. 32, 1602\u20131611 https:\/\/doi.org\/10.1523\/JNEUROSCI.5601-11.2012 (2012).","journal-title":"J. Neurosci."},{"key":"1262_CR90","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abp8869","volume":"14","author":"RG Langston","year":"2022","unstructured":"Langston, R. G. et al. Association of a common genetic variant with Parkinson\u2019s disease is mediated by microglia. Sci. Transl. Med. 14, eabp8869 https:\/\/doi.org\/10.1126\/scitranslmed.abp8869 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1262_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00297-9","volume":"8","author":"D Ahmadi Rastegar","year":"2022","unstructured":"Ahmadi Rastegar, D. et al. Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages. NPJ Parkinsons Dis. 8, 34 https:\/\/doi.org\/10.1038\/s41531-022-00297-9 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1262_CR92","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska, A. et al. Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell 173, 1073\u20131081 https:\/\/doi.org\/10.1016\/j.cell.2018.05.003 (2018).","journal-title":"Cell"},{"key":"1262_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.896852","volume":"14","author":"YJ Xu","year":"2022","unstructured":"Xu, Y. J., Au, N. P. B. & Ma, C. H. E. Functional and phenotypic diversity of microglia: implication for microglia-based therapies for Alzheimer\u2019s disease. Front. Aging Neurosci. 14, 896852 https:\/\/doi.org\/10.3389\/fnagi.2022.896852 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"1262_CR94","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/mds.29297","volume":"38","author":"D Jennings","year":"2023","unstructured":"Jennings, D. et al. LRRK2 inhibition by BIIB122 in healthy participants and patients with Parkinson\u2019s disease. Mov. Disord. 38, 386\u2013398 https:\/\/doi.org\/10.1002\/mds.29297 (2023).","journal-title":"Mov. Disord."},{"key":"1262_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00880-7","volume":"20","author":"MT Maloney","year":"2025","unstructured":"Maloney, M. T. et al. LRRK2 kinase activity regulates Parkinson\u2019s disease-relevant lipids at the lysosome. Mol. Neurodegener. 20, 89 https:\/\/doi.org\/10.1186\/s13024-025-00880-7 (2025).","journal-title":"Mol. Neurodegener."},{"key":"1262_CR96","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s40263-026-01275-y","volume":"40","author":"N Dzamko","year":"2026","unstructured":"Dzamko, N. Pathological protein targets in Parkinson\u2019s disease: progress towards the development of disease-modifying therapies. CNS Drugs 40, 509\u2013522 https:\/\/doi.org\/10.1007\/s40263-026-01275-y (2026).","journal-title":"CNS Drugs"},{"key":"1262_CR97","doi-asserted-by":"publisher","DOI":"10.1002\/mds.70397","author":"E Sammler","year":"2026","unstructured":"Sammler, E. et al. Addressing the challenges of translating LRRK2 biology into disease-modifying therapies: the LRRK2 investigative therapeutics exchange initiative. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.70397 (2026).","journal-title":"Mov. Disord."},{"key":"1262_CR98","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ncb2374","volume":"14","author":"PJ Cullen","year":"2011","unstructured":"Cullen, P. J. & Korswagen, H. C. Sorting nexins provide diversity for retromer-dependent trafficking events. Nat. Cell Biol. 14, 29\u201337 https:\/\/doi.org\/10.1038\/ncb2374 (2011).","journal-title":"Nat. Cell Biol."},{"key":"1262_CR99","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41583-024-00812-2","volume":"25","author":"R Coukos","year":"2024","unstructured":"Coukos, R. & Krainc, D. Key genes and convergent pathogenic mechanisms in Parkinson disease. Nat. Rev. Neurosci. 25, 393\u2013413 https:\/\/doi.org\/10.1038\/s41583-024-00812-2 (2024).","journal-title":"Nat. Rev. Neurosci."},{"key":"1262_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38719-8","volume":"14","author":"JL Daly","year":"2023","unstructured":"Daly, J. L. et al. Multi-omic approach characterises the neuroprotective role of retromer in regulating lysosomal health. Nat. Commun. 14, 3086 https:\/\/doi.org\/10.1038\/s41467-023-38719-8 (2023).","journal-title":"Nat. Commun."},{"key":"1262_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2014.07.014","volume":"71","author":"E Miura","year":"2014","unstructured":"Miura, E. et al. VPS35 dysfunction impairs lysosomal degradation of \u03b1-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson\u2019s disease. Neurobiol. Dis. 71, 1\u201313 https:\/\/doi.org\/10.1016\/j.nbd.2014.07.014 (2014).","journal-title":"Neurobiol. Dis."},{"key":"1262_CR102","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","volume":"89","author":"A Zimprich","year":"2011","unstructured":"Zimprich, A. et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet. 89, 168\u2013175 https:\/\/doi.org\/10.1016\/j.ajhg.2011.06.008 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"1262_CR103","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/tra.12136","volume":"15","author":"J Follett","year":"2014","unstructured":"Follett, J. et al. The Vps35 D620N mutation linked to Parkinson\u2019s disease disrupts the cargo sorting function of retromer. Traffic 15, 230\u2013244 https:\/\/doi.org\/10.1111\/tra.12136 (2014).","journal-title":"Traffic"},{"key":"1262_CR104","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.cub.2014.06.024","volume":"24","author":"IJ McGough","year":"2014","unstructured":"McGough, I. J. et al. Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation. Curr. Biol. 24, 1670\u20131676 https:\/\/doi.org\/10.1016\/j.cub.2014.06.024 (2014).","journal-title":"Curr. Biol."},{"key":"1262_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4828","volume":"5","author":"E Zavodszky","year":"2014","unstructured":"Zavodszky, E. et al. Mutation in VPS35 associated with Parkinson\u2019s disease impairs WASH complex association and inhibits autophagy. Nat. Commun. 5, 3828 https:\/\/doi.org\/10.1038\/ncomms4828 (2014).","journal-title":"Nat. Commun."},{"key":"1262_CR106","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1093\/hmg\/ddy224","volume":"27","author":"ET Williams","year":"2018","unstructured":"Williams, E. T. et al. Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting. Hum. Mol. Genet. 27, 3189\u20133205 https:\/\/doi.org\/10.1093\/hmg\/ddy224 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"1262_CR107","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1083\/jcb.201703015","volume":"216","author":"B Simonetti","year":"2017","unstructured":"Simonetti, B., Danson, C. M., Heesom, K. J. & Cullen, P. J. Sequence-dependent cargo recognition by SNX-BARs mediates retromer-independent transport of CI-MPR. J. Cell Biol. 216, 3695\u20133712 https:\/\/doi.org\/10.1083\/jcb.201703015 (2017).","journal-title":"J. Cell Biol."},{"key":"1262_CR108","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj1205","volume":"9","author":"P Pal","year":"2023","unstructured":"Pal, P. et al. Parkinson\u2019s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B. Sci. Adv. 9, eadj1205 https:\/\/doi.org\/10.1126\/sciadv.adj1205 (2023).","journal-title":"Sci. Adv."},{"key":"1262_CR109","doi-asserted-by":"publisher","first-page":"10613","DOI":"10.1523\/JNEUROSCI.0042-15.2015","volume":"35","author":"FL Tang","year":"2015","unstructured":"Tang, F. L. et al. VPS35 in dopamine neurons is required for endosome-to-Golgi retrieval of Lamp2a, a receptor of chaperone-mediated autophagy that is critical for \u03b1-synuclein degradation and prevention of pathogenesis of Parkinson\u2019s disease. J. Neurosci. 35, 10613\u201310628 https:\/\/doi.org\/10.1523\/JNEUROSCI.0042-15.2015 (2015).","journal-title":"J. Neurosci."},{"key":"1262_CR110","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.neuron.2012.11.033","volume":"77","author":"DA MacLeod","year":"2013","unstructured":"MacLeod, D. A. et al. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson\u2019s disease risk. Neuron 77, 425\u2013439 https:\/\/doi.org\/10.1016\/j.neuron.2012.11.033 (2013).","journal-title":"Neuron"},{"key":"1262_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00609-7","volume":"9","author":"M Bu","year":"2023","unstructured":"Bu, M. et al. Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine physiology in VPS35 p.D620N knock-in mice. NPJ Parkinsons Dis. 9, 167 https:\/\/doi.org\/10.1038\/s41531-023-00609-7 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1262_CR112","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1042\/BCJ20180248","volume":"475","author":"R Mir","year":"2018","unstructured":"Mir, R. et al. The Parkinson\u2019s disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human. Biochem. J. 475, 1861\u20131883 https:\/\/doi.org\/10.1042\/BCJ20180248 (2018).","journal-title":"Biochem. J."},{"key":"1262_CR113","doi-asserted-by":"publisher","first-page":"149","DOI":"10.7150\/ijbs.5617","volume":"9","author":"F Bi","year":"2013","unstructured":"Bi, F., Li, F., Huang, C. & Zhou, H. Pathogenic mutation in VPS35 impairs its protection against MPP+ cytotoxicity. Int. J. Biol. Sci. 9, 149\u2013155 https:\/\/doi.org\/10.7150\/ijbs.5617 (2013).","journal-title":"Int. J. Biol. Sci."},{"key":"1262_CR114","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.celrep.2015.08.001","volume":"12","author":"FL Tang","year":"2015","unstructured":"Tang, F. L. et al. VPS35 deficiency or mutation causes dopaminergic neuronal loss by impairing mitochondrial fusion and function. Cell Rep. 12, 1631\u20131643 https:\/\/doi.org\/10.1016\/j.celrep.2015.08.001 (2015).","journal-title":"Cell Rep."},{"key":"1262_CR115","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1016\/j.bbadis.2017.07.032","volume":"1863","author":"L Zhou","year":"2017","unstructured":"Zhou, L., Wang, W., Hoppel, C., Liu, J. & Zhu, X. Parkinson\u2019s disease-associated pathogenic VPS35 mutation causes complex I deficits. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 2791\u20132795 https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.032 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"1262_CR116","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm.3983","volume":"22","author":"W Wang","year":"2016","unstructured":"Wang, W. et al. Parkinson\u2019s disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes. Nat. Med. 22, 54\u201363 https:\/\/doi.org\/10.1038\/nm.3983 (2016).","journal-title":"Nat. Med."},{"key":"1262_CR117","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.cub.2010.05.066","volume":"20","author":"E Braschi","year":"2010","unstructured":"Braschi, E. et al. Vps35 mediates vesicle transport between the mitochondria and peroxisomes. Curr. Biol. 20, 1310\u20131315 https:\/\/doi.org\/10.1016\/j.cub.2010.05.066 (2010).","journal-title":"Curr. Biol."},{"key":"1262_CR118","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019102539","volume":"39","author":"TA Ryan","year":"2020","unstructured":"Ryan, T. A. et al. Tollip coordinates parkin-dependent trafficking of mitochondrial-derived vesicles. EMBO J. 39, e102539 https:\/\/doi.org\/10.15252\/embj.2019102539 (2020).","journal-title":"EMBO J."},{"key":"1262_CR119","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/humu.21527","volume":"32","author":"JS Park","year":"2011","unstructured":"Park, J. S. et al. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism. Hum. Mutat. 32, 956\u2013964 https:\/\/doi.org\/10.1002\/humu.21527 (2011).","journal-title":"Hum. Mutat."},{"key":"1262_CR120","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/ng1884","volume":"38","author":"A Ramirez","year":"2006","unstructured":"Ramirez, A. et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38, 1184\u20131191 https:\/\/doi.org\/10.1038\/ng1884 (2006).","journal-title":"Nat. Genet."},{"key":"1262_CR121","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1073\/pnas.1112368109","volume":"109","author":"B Dehay","year":"2012","unstructured":"Dehay, B. et al. Loss of P-type ATPase ATP13A2\/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proc. Natl Acad. Sci. USA 109, 9611\u20139616 https:\/\/doi.org\/10.1073\/pnas.1112368109 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR122","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1093\/hmg\/ddt572","volume":"23","author":"T Tsunemi","year":"2014","unstructured":"Tsunemi, T. & Krainc, D. Zn2+ dyshomeostasis caused by loss of ATP13A2\/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation. Hum. Mol. Genet. 23, 2791\u20132801 https:\/\/doi.org\/10.1093\/hmg\/ddt572 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"1262_CR123","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.stemcr.2019.12.005","volume":"14","author":"T Ahfeldt","year":"2020","unstructured":"Ahfeldt, T. et al. Pathogenic pathways in early-onset autosomal recessive Parkinson\u2019s disease discovered using isogenic human dopaminergic neurons. Stem Cell Rep. 14, 75\u201390 https:\/\/doi.org\/10.1016\/j.stemcr.2019.12.005 (2020).","journal-title":"Stem Cell Rep."},{"key":"1262_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052689","volume":"22","author":"J Si","year":"2021","unstructured":"Si, J. et al. ATP13A2 regulates cellular \u03b1-synuclein multimerization, membrane association, and externalization. Int. J. Mol. Sci. 22, 2689 https:\/\/doi.org\/10.3390\/ijms22052689 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1262_CR125","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1523\/JNEUROSCI.5575-11.2012","volume":"32","author":"M Usenovic","year":"2012","unstructured":"Usenovic, M., Tresse, E., Mazzulli, J. R., Taylor, J. P. & Krainc, D. Deficiency of ATP13A2 leads to lysosomal dysfunction, \u03b1-synuclein accumulation, and neurotoxicity. J. Neurosci. 32, 4240\u20134246 https:\/\/doi.org\/10.1523\/JNEUROSCI.5575-11.2012 (2012).","journal-title":"J. Neurosci."},{"key":"1262_CR126","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1523\/JNEUROSCI.0632-14.2015","volume":"35","author":"LR Kett","year":"2015","unstructured":"Kett, L. R. et al. \u03b1-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal parkinsonism protein Atp13a2. J. Neurosci. 35, 5724\u20135742 https:\/\/doi.org\/10.1523\/JNEUROSCI.0632-14.2015 (2015).","journal-title":"J. Neurosci."},{"key":"1262_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00748-5","volume":"10","author":"ML Erb","year":"2024","unstructured":"Erb, M. L., Sipple, K., Levine, N., Chen, X. & Moore, D. J. Adult-onset deletion of ATP13A2 in mice induces progressive nigrostriatal pathway dopaminergic degeneration and lysosomal abnormalities. NPJ Parkinsons Dis. 10, 133 https:\/\/doi.org\/10.1038\/s41531-024-00748-5 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1262_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105513","volume":"159","author":"ME Johnson","year":"2021","unstructured":"Johnson, M. E. et al. Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological \u03b1-synuclein spread in the prodromal preformed fibrils model in young mice. Neurobiol. Dis. 159, 105513 https:\/\/doi.org\/10.1016\/j.nbd.2021.105513 (2021).","journal-title":"Neurobiol. Dis."},{"key":"1262_CR129","doi-asserted-by":"publisher","first-page":"15281","DOI":"10.1523\/JNEUROSCI.1629-14.2014","volume":"34","author":"T Tsunemi","year":"2014","unstructured":"Tsunemi, T., Hamada, K. & Krainc, D. ATP13A2\/PARK9 regulates secretion of exosomes and \u03b1-synuclein. J. Neurosci. 34, 15281\u201315287 https:\/\/doi.org\/10.1523\/JNEUROSCI.1629-14.2014 (2014).","journal-title":"J. Neurosci."},{"key":"1262_CR130","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1016\/j.molcel.2021.08.017","volume":"81","author":"SI Sim","year":"2021","unstructured":"Sim, S. I., von Bulow, S., Hummer, G. & Park, E. Structural basis of polyamine transport by human ATP13A2 (PARK9). Mol. Cell 81, 4635\u20134649.e8 https:\/\/doi.org\/10.1016\/j.molcel.2021.08.017 (2021).","journal-title":"Mol. Cell"},{"key":"1262_CR131","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41586-020-1968-7","volume":"578","author":"S van Veen","year":"2020","unstructured":"van Veen, S. et al. ATP13A2 deficiency disrupts lysosomal polyamine export. Nature 578, 419\u2013424 https:\/\/doi.org\/10.1038\/s41586-020-1968-7 (2020).","journal-title":"Nature"},{"key":"1262_CR132","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1016\/j.molcel.2021.10.002","volume":"81","author":"J Tillinghast","year":"2021","unstructured":"Tillinghast, J., Drury, S., Bowser, D., Benn, A. & Lee, K. P. K. Structural mechanisms for gating and ion selectivity of the human polyamine transporter ATP13A2. Mol. Cell 81, 4650\u20134662.e4 https:\/\/doi.org\/10.1016\/j.molcel.2021.10.002 (2021).","journal-title":"Mol. Cell"},{"key":"1262_CR133","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1016\/j.molcel.2021.11.001","volume":"81","author":"A Tomita","year":"2021","unstructured":"Tomita, A. et al. Cryo-EM reveals mechanistic insights into lipid-facilitated polyamine export by human ATP13A2. Mol. Cell 81, 4799\u20134809.e5 https:\/\/doi.org\/10.1016\/j.molcel.2021.11.001 (2021).","journal-title":"Mol. Cell"},{"key":"1262_CR134","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ng.300","volume":"41","author":"AD Gitler","year":"2009","unstructured":"Gitler, A. D. et al. \u03b1-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 41, 308\u2013315 https:\/\/doi.org\/10.1038\/ng.300 (2009).","journal-title":"Nat. Genet."},{"key":"1262_CR135","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.bbamem.2015.04.008","volume":"1848","author":"DE Rinaldi","year":"2015","unstructured":"Rinaldi, D. E., Corradi, G. R., Cuesta, L. M., Adamo, H. P. & de Tezanos Pinto, F. The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity. Biochim. Biophys. Acta Biomembr. 1848, 1646\u20131655 https:\/\/doi.org\/10.1016\/j.bbamem.2015.04.008 (2015).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"1262_CR136","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1093\/hmg\/ddz136","volume":"28","author":"S Jinn","year":"2019","unstructured":"Jinn, S. et al. Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease. Hum. Mol. Genet. 28, 3244\u20133254 https:\/\/doi.org\/10.1093\/hmg\/ddz136 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"1262_CR137","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cell.2015.08.002","volume":"162","author":"C Cang","year":"2015","unstructured":"Cang, C., Aranda, K., Seo, Y. J., Gasnier, B. & Ren, D. TMEM175 is an organelle K+ channel regulating lysosomal function. Cell 162, 1101\u20131112 https:\/\/doi.org\/10.1016\/j.cell.2015.08.002 (2015).","journal-title":"Cell"},{"key":"1262_CR138","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41586-021-03185-z","volume":"591","author":"J Wie","year":"2021","unstructured":"Wie, J. et al. A growth-factor-activated lysosomal K+ channel regulates Parkinson\u2019s pathology. Nature 591, 431\u2013437 https:\/\/doi.org\/10.1038\/s41586-021-03185-z (2021).","journal-title":"Nature"},{"key":"1262_CR139","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.cell.2022.05.021","volume":"185","author":"M Hu","year":"2022","unstructured":"Hu, M. et al. Parkinson\u2019s disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes. Cell 185, 2292\u20132308.e20 https:\/\/doi.org\/10.1016\/j.cell.2022.05.021 (2022).","journal-title":"Cell"},{"key":"1262_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.70008","volume":"240","author":"T Schulze","year":"2025","unstructured":"Schulze, T. et al. Unraveling pH regulation of TMEM175, an endolysosomal cation channel with a role in Parkinson\u2019s disease. J. Cell Physiol. 240, e70008 https:\/\/doi.org\/10.1002\/jcp.70008 (2025).","journal-title":"J. Cell Physiol."},{"key":"1262_CR141","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2503909123","volume":"123","author":"T Schulze","year":"2026","unstructured":"Schulze, T. et al. Proton-selective conductance and gating of the lysosomal cation channel TMEM175. Proc. Natl Acad. Sci. USA 123, e2503909123 https:\/\/doi.org\/10.1073\/pnas.2503909123 (2026).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR142","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202501145","volume":"225","author":"E Riederer","year":"2026","unstructured":"Riederer, E. et al. TMEM175 does not function as a proton-selective ion channel to prevent lysosomal over-acidification. J. Cell Biol. 225, e202501145 https:\/\/doi.org\/10.1083\/jcb.202501145 (2026).","journal-title":"J. Cell Biol."},{"key":"1262_CR143","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1073\/pnas.1616332114","volume":"114","author":"S Jinn","year":"2017","unstructured":"Jinn, S. et al. TMEM175 deficiency impairs lysosomal and mitochondrial function and increases \u03b1-synuclein aggregation. Proc. Natl Acad. Sci. USA 114, 2389\u20132394 https:\/\/doi.org\/10.1073\/pnas.1616332114 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR144","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1016\/j.neuron.2025.07.029","volume":"113","author":"X Zhu","year":"2025","unstructured":"Zhu, X. et al. Structural insights into the activation of TMEM175 by small molecule. Neuron 113, 3567\u20133581.e9 https:\/\/doi.org\/10.1016\/j.neuron.2025.07.029 (2025).","journal-title":"Neuron"},{"key":"1262_CR145","doi-asserted-by":"publisher","first-page":"C715","DOI":"10.1152\/ajpcell.00951.2025","volume":"330","author":"K Li","year":"2026","unstructured":"Li, K. et al. Activation of TMEM175 lysosomal ion channels by CysLT1 receptor antagonists. Am. J. Physiol. Cell Physiol. 330, C715\u2013C726 https:\/\/doi.org\/10.1152\/ajpcell.00951.2025 (2026).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1262_CR146","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1073\/pnas.1318306111","volume":"111","author":"A Beilina","year":"2014","unstructured":"Beilina, A. et al. Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease. Proc. Natl Acad. Sci. USA 111, 2626\u20132631 https:\/\/doi.org\/10.1073\/pnas.1318306111 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR147","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/ana.26094","volume":"90","author":"D Lai","year":"2021","unstructured":"Lai, D. et al. Genomewide association studies of LRRK2 modifiers of Parkinson\u2019s disease. Ann. Neurol. 90, 76\u201388 https:\/\/doi.org\/10.1002\/ana.26094 (2021).","journal-title":"Ann. Neurol."},{"key":"1262_CR148","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1002\/mds.27516","volume":"33","author":"H Darvish","year":"2018","unstructured":"Darvish, H. et al. Identification of a large homozygous VPS13C deletion in a patient with early-onset parkinsonism. Mov. Disord. 33, 1968\u20131970 https:\/\/doi.org\/10.1002\/mds.27516 (2018).","journal-title":"Mov. Disord."},{"key":"1262_CR149","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203769119","volume":"119","author":"S Cai","year":"2022","unstructured":"Cai, S. et al. In situ architecture of the lipid transport protein VPS13C at ER\u2013lysosome membrane contacts. Proc. Natl Acad. Sci. USA 119, e2203769119 https:\/\/doi.org\/10.1073\/pnas.2203769119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR150","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1083\/jcb.201807019","volume":"217","author":"N Kumar","year":"2018","unstructured":"Kumar, N. et al. VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites. J. Cell Biol. 217, 3625\u20133639 https:\/\/doi.org\/10.1083\/jcb.201807019 (2018).","journal-title":"J. Cell Biol."},{"key":"1262_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2021.159003","volume":"1866","author":"M Leonzino","year":"2021","unstructured":"Leonzino, M., Reinisch, K. M. & De Camilli, P. Insights into VPS13 properties and function reveal a new mechanism of eukaryotic lipid transport. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1866, 159003 https:\/\/doi.org\/10.1016\/j.bbalip.2021.159003 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"1262_CR152","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41556-025-01653-6","volume":"27","author":"X Wang","year":"2025","unstructured":"Wang, X. et al. The bridge-like lipid transport protein VPS13C\/PARK23 mediates ER\u2013lysosome contacts following lysosome damage. Nat. Cell Biol. 27, 776\u2013789 https:\/\/doi.org\/10.1038\/s41556-025-01653-6 (2025).","journal-title":"Nat. Cell Biol."},{"key":"1262_CR153","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202304042","volume":"223","author":"LF Schr\u04e7der","year":"2024","unstructured":"Schr\u04e7der, L. F. et al. VPS13C regulates phospho-Rab10-mediated lysosomal function in human dopaminergic neurons. J. Cell Biol. 223, e202304042 https:\/\/doi.org\/10.1083\/jcb.202304042 (2024).","journal-title":"J. Cell Biol."},{"key":"1262_CR154","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.neuron.2022.04.020","volume":"110","author":"S Kim","year":"2022","unstructured":"Kim, S., Coukos, R., Gao, F. & Krainc, D. Dysregulation of organelle membrane contact sites in neurological diseases. Neuron 110, 2386\u20132408 https:\/\/doi.org\/10.1016\/j.neuron.2022.04.020 (2022).","journal-title":"Neuron"},{"key":"1262_CR155","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh3347","volume":"9","author":"W Peng","year":"2023","unstructured":"Peng, W., Schroder, L. F., Song, P., Wong, Y. C. & Krainc, D. Parkin regulates amino acid homeostasis at mitochondria-lysosome (M\/L) contact sites in Parkinson\u2019s disease. Sci. Adv. 9, eadh3347 https:\/\/doi.org\/10.1126\/sciadv.adh3347 (2023).","journal-title":"Sci. Adv."},{"key":"1262_CR156","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22113-3","volume":"12","author":"S Kim","year":"2021","unstructured":"Kim, S., Wong, Y. C., Gao, F. & Krainc, D. Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson\u2019s disease. Nat. Commun. 12, 1807 https:\/\/doi.org\/10.1038\/s41467-021-22113-3 (2021).","journal-title":"Nat. Commun."},{"key":"1262_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman, B. T. et al. National Institute on Aging\u2013Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 8, 1\u201313 https:\/\/doi.org\/10.1016\/j.jalz.2011.10.007 (2012).","journal-title":"Alzheimers Dement."},{"key":"1262_CR158","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.neurobiolaging.2004.02.027","volume":"25","author":"AM Cataldo","year":"2004","unstructured":"Cataldo, A. M. et al. A\u03b2 localization in abnormal endosomes: association with earliest A\u03b2 elevations in AD and down syndrome. Neurobiol. Aging 25, 1263\u20131272 https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.02.027 (2004).","journal-title":"Neurobiol. Aging"},{"key":"1262_CR159","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s0002-9440(10)64538-5","volume":"157","author":"AM Cataldo","year":"2000","unstructured":"Cataldo, A. M. et al. Endocytic pathway abnormalities precede amyloid \u03b2 deposition in sporadic Alzheimer\u2019s disease and down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 157, 277\u2013286 https:\/\/doi.org\/10.1016\/s0002-9440(10)64538-5 (2000).","journal-title":"Am. J. Pathol."},{"key":"1262_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105576","volume":"162","author":"MP Szabo","year":"2022","unstructured":"Szabo, M. P., Mishra, S., Knupp, A. & Young, J. E. The role of Alzheimer\u2019s disease risk genes in endolysosomal pathways. Neurobiol. Dis. 162, 105576 https:\/\/doi.org\/10.1016\/j.nbd.2021.105576 (2022).","journal-title":"Neurobiol. Dis."},{"key":"1262_CR161","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41556-025-01623-y","volume":"27","author":"CC Chou","year":"2025","unstructured":"Chou, C. C. et al. Proteostasis and lysosomal repair deficits in transdifferentiated neurons of Alzheimer\u2019s disease. Nat. Cell Biol. 27, 619\u2013632 https:\/\/doi.org\/10.1038\/s41556-025-01623-y (2025).","journal-title":"Nat. Cell Biol."},{"key":"1262_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107719","volume":"31","author":"A Knupp","year":"2020","unstructured":"Knupp, A. et al. Depletion of the AD risk gene SORL1 selectively impairs neuronal endosomal traffic independent of amyloidogenic APP processing. Cell Rep. 31, 107719 https:\/\/doi.org\/10.1016\/j.celrep.2020.107719 (2020).","journal-title":"Cell Rep."},{"key":"1262_CR163","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","volume":"53","author":"J Schwartzentruber","year":"2021","unstructured":"Schwartzentruber, J. et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer\u2019s disease risk genes. Nat. Genet. 53, 392\u2013402 https:\/\/doi.org\/10.1038\/s41588-020-00776-w (2021).","journal-title":"Nat. Genet."},{"key":"1262_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5998","volume":"5","author":"K Moreau","year":"2014","unstructured":"Moreau, K. et al. PICALM modulates autophagy activity and tau accumulation. Nat. Commun. 5, 4998 https:\/\/doi.org\/10.1038\/ncomms5998 (2014).","journal-title":"Nat. Commun."},{"key":"1262_CR165","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/353844a0","volume":"353","author":"MC Chartier-Harlin","year":"1991","unstructured":"Chartier-Harlin, M. C. et al. Early-onset Alzheimer\u2019s disease caused by mutations at codon 717 of the \u03b2-amyloid precursor protein gene. Nature 353, 844\u2013846 https:\/\/doi.org\/10.1038\/353844a0 (1991).","journal-title":"Nature"},{"key":"1262_CR166","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature 375, 754\u2013760 https:\/\/doi.org\/10.1038\/375754a0 (1995).","journal-title":"Nature"},{"key":"1262_CR167","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1126\/science.7638621","volume":"269","author":"E Levy-Lahad","year":"1995","unstructured":"Levy-Lahad, E. et al. A familial Alzheimer\u2019s disease locus on chromosome 1. Science 269, 970\u2013973 https:\/\/doi.org\/10.1126\/science.7638621 (1995).","journal-title":"Science"},{"key":"1262_CR168","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","volume":"15","author":"F Panza","year":"2019","unstructured":"Panza, F., Lozupone, M., Logroscino, G. & Imbimbo, B. P. A critical appraisal of amyloid-\u03b2-targeting therapies for Alzheimer disease. Nat. Rev. Neurol. 15, 73\u201388 https:\/\/doi.org\/10.1038\/s41582-018-0116-6 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"1262_CR169","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.2111583","volume":"248","author":"FS Esch","year":"1990","unstructured":"Esch, F. S. et al. Cleavage of amyloid \u03b2 peptide during constitutive processing of its precursor. Science 248, 1122\u20131124 https:\/\/doi.org\/10.1126\/science.2111583 (1990).","journal-title":"Science"},{"key":"1262_CR170","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/34910","volume":"391","author":"B De Strooper","year":"1998","unstructured":"De Strooper, B. et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387\u2013390 https:\/\/doi.org\/10.1038\/34910 (1998).","journal-title":"Nature"},{"key":"1262_CR171","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/35017108","volume":"2","author":"Z Zhang","year":"2000","unstructured":"Zhang, Z. et al. Presenilins are required for \u03b3-secretase cleavage of \u03b2-APP and transmembrane cleavage of Notch-1. Nat. Cell Biol. 2, 463\u2013465 https:\/\/doi.org\/10.1038\/35017108 (2000).","journal-title":"Nat. Cell Biol."},{"key":"1262_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172415","volume":"856","author":"M Yuksel","year":"2019","unstructured":"Yuksel, M. & Tacal, O. Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer\u2019s disease development: an up-to-date review. Eur. J. Pharmacol. 856, 172415 https:\/\/doi.org\/10.1016\/j.ejphar.2019.172415 (2019).","journal-title":"Eur. J. Pharmacol."},{"key":"1262_CR173","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1523\/JNEUROSCI.2272-11.2012","volume":"32","author":"AW Fjorback","year":"2012","unstructured":"Fjorback, A. W. et al. Retromer binds the FANSHY sorting motif in SorLA to regulate amyloid precursor protein sorting and processing. J. Neurosci. 32, 1467\u20131480 https:\/\/doi.org\/10.1523\/JNEUROSCI.2272-11.2012 (2012).","journal-title":"J. Neurosci."},{"key":"1262_CR174","doi-asserted-by":"publisher","DOI":"10.1002\/alz.084834","volume":"20","author":"GA Petsko","year":"2024","unstructured":"Petsko, G. A. An introduction to SORL1-retromer structure\/function and its role in Alzheimer\u2019s disease. Alzheimers Dement. 20, e084834 https:\/\/doi.org\/10.1002\/alz.084834 (2024).","journal-title":"Alzheimers Dement."},{"key":"1262_CR175","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41582-025-01062-1","volume":"21","author":"L De Deyn","year":"2025","unstructured":"De Deyn, L. & Sleegers, K. The impact of rare genetic variants on Alzheimer disease. Nat. Rev. Neurol. 21, 127\u2013139 https:\/\/doi.org\/10.1038\/s41582-025-01062-1 (2025).","journal-title":"Nat. Rev. Neurol."},{"key":"1262_CR176","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41588-022-01208-7","volume":"54","author":"H Holstege","year":"2022","unstructured":"Holstege, H. et al. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer\u2019s disease. Nat. Genet. 54, 1786\u20131794 https:\/\/doi.org\/10.1038\/s41588-022-01208-7 (2022).","journal-title":"Nat. Genet."},{"key":"1262_CR177","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01070-6","volume":"14","author":"C Schramm","year":"2022","unstructured":"Schramm, C. et al. Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes. Genom. Med. 14, 69 https:\/\/doi.org\/10.1186\/s13073-022-01070-6 (2022).","journal-title":"Genom. Med."},{"key":"1262_CR178","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1097\/01.jnen.0000228205.19915.20","volume":"65","author":"SE Dodson","year":"2006","unstructured":"Dodson, S. E. et al. LR11\/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. J. Neuropathol. Exp. Neurol. 65, 866\u2013872 https:\/\/doi.org\/10.1097\/01.jnen.0000228205.19915.20 (2006).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1262_CR179","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1001\/archneurol.2009.22","volume":"66","author":"QL Ma","year":"2009","unstructured":"Ma, Q. L. et al. Reduction of SorLA\/LR11, a sorting protein limiting \u03b2-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch. Neurol. 66, 448\u2013457 https:\/\/doi.org\/10.1001\/archneurol.2009.22 (2009).","journal-title":"Arch. Neurol."},{"key":"1262_CR180","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2212180120","volume":"120","author":"AMG Jensen","year":"2023","unstructured":"Jensen, A. M. G. et al. Dimerization of the Alzheimer\u2019s disease pathogenic receptor SORLA regulates its association with retromer. Proc. Natl Acad. Sci. USA 120, e2212180120 https:\/\/doi.org\/10.1073\/pnas.2212180120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR181","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/ana.20667","volume":"58","author":"SA Small","year":"2005","unstructured":"Small, S. A. et al. Model-guided microarray implicates the retromer complex in Alzheimer\u2019s disease. Ann. Neurol. 58, 909\u2013919 https:\/\/doi.org\/10.1002\/ana.20667 (2005).","journal-title":"Ann. Neurol."},{"key":"1262_CR182","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.stem.2015.02.004","volume":"16","author":"JE Young","year":"2015","unstructured":"Young, J. E. et al. Elucidating molecular phenotypes caused by the SORL1 Alzheimer\u2019s disease genetic risk factor using human induced pluripotent stem cells. Cell Stem Cell 16, 373\u2013385 https:\/\/doi.org\/10.1016\/j.stem.2015.02.004 (2015).","journal-title":"Cell Stem Cell"},{"key":"1262_CR183","doi-asserted-by":"publisher","first-page":"7996","DOI":"10.1523\/JNEUROSCI.0206-16.2016","volume":"36","author":"TY Huang","year":"2016","unstructured":"Huang, T. Y. et al. SNX27 and SORLA interact to reduce amyloidogenic subcellular distribution and processing of amyloid precursor protein. J. Neurosci. 36, 7996\u20138011 https:\/\/doi.org\/10.1523\/JNEUROSCI.0206-16.2016 (2016).","journal-title":"J. Neurosci."},{"key":"1262_CR184","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04182-9","volume":"79","author":"S Mishra","year":"2022","unstructured":"Mishra, S. et al. The Alzheimer\u2019s gene SORL1 is a regulator of endosomal traffic and recycling in human neurons. Cell Mol. Life Sci. 79, 162 https:\/\/doi.org\/10.1007\/s00018-022-04182-9 (2022).","journal-title":"Cell Mol. Life Sci."},{"key":"1262_CR185","doi-asserted-by":"publisher","first-page":"13461","DOI":"10.1073\/pnas.0503689102","volume":"102","author":"OM Andersen","year":"2005","unstructured":"Andersen, O. M. et al. Neuronal sorting protein-related receptor sorLA\/LR11 regulates processing of the amyloid precursor protein. Proc. Natl Acad. Sci. USA 102, 13461\u201313466 https:\/\/doi.org\/10.1073\/pnas.0503689102 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR186","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007747","volume":"6","author":"S Caglayan","year":"2014","unstructured":"Caglayan, S. et al. Lysosomal sorting of amyloid-\u03b2 by the SORLA receptor is impaired by a familial Alzheimer\u2019s disease mutation. Sci. Transl. Med. 6, 223ra220 https:\/\/doi.org\/10.1126\/scitranslmed.3007747 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1262_CR187","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/glia.70009","volume":"73","author":"S Mishra","year":"2025","unstructured":"Mishra, S. et al. The Alzheimer\u2019s disease gene SORL1 regulates lysosome function in human microglia. Glia 73, 1329\u20131348 https:\/\/doi.org\/10.1002\/glia.70009 (2025).","journal-title":"Glia"},{"key":"1262_CR188","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nchembio.1508","volume":"10","author":"VJ Mecozzi","year":"2014","unstructured":"Mecozzi, V. J. et al. Pharmacological chaperones stabilize retromer to limit APP processing. Nat. Chem. Biol. 10, 443\u2013449 https:\/\/doi.org\/10.1038\/nchembio.1508 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"1262_CR189","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.stemcr.2018.01.031","volume":"10","author":"JE Young","year":"2018","unstructured":"Young, J. E. et al. Stabilizing the retromer complex in a human stem cell model of Alzheimer\u2019s disease reduces TAU phosphorylation independently of amyloid precursor protein. Stem Cell Rep. 10, 1046\u20131058 https:\/\/doi.org\/10.1016\/j.stemcr.2018.01.031 (2018).","journal-title":"Stem Cell Rep."},{"key":"1262_CR190","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat. Genet. 51, 414\u2013430 https:\/\/doi.org\/10.1038\/s41588-019-0358-2 (2019).","journal-title":"Nat. Genet."},{"key":"1262_CR191","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01285-5","volume":"10","author":"E Lambert","year":"2022","unstructured":"Lambert, E. et al. The Alzheimer susceptibility gene BIN1 induces isoform-dependent neurotoxicity through early endosome defects. Acta Neuropathol. Commun. 10, 4 https:\/\/doi.org\/10.1186\/s40478-021-01285-5 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"1262_CR192","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold, D. et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat. Genet. 41, 1088\u20131093 https:\/\/doi.org\/10.1038\/ng.440 (2009).","journal-title":"Nat. Genet."},{"key":"1262_CR193","doi-asserted-by":"publisher","first-page":"102","DOI":"10.15252\/embr.201642738","volume":"18","author":"F Ubelmann","year":"2017","unstructured":"Ubelmann, F. et al. Bin1 and CD2AP polarise the endocytic generation of beta-amyloid. EMBO Rep. 18, 102\u2013122 https:\/\/doi.org\/10.15252\/embr.201642738 (2017).","journal-title":"EMBO Rep."},{"key":"1262_CR194","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.celrep.2016.09.063","volume":"17","author":"S Calafate","year":"2016","unstructured":"Calafate, S., Flavin, W., Verstreken, P. & Moechars, D. Loss of Bin1 promotes the propagation of tau pathology. Cell Rep. 17, 931\u2013940 https:\/\/doi.org\/10.1016\/j.celrep.2016.09.063 (2016).","journal-title":"Cell Rep."},{"key":"1262_CR195","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002470","volume":"22","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice. PLoS Biol. 22, e3002470 https:\/\/doi.org\/10.1371\/journal.pbio.3002470 (2024).","journal-title":"PLoS Biol."},{"key":"1262_CR196","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev, E. I. et al. Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature 376, 775\u2013778 https:\/\/doi.org\/10.1038\/376775a0 (1995).","journal-title":"Nature"},{"key":"1262_CR197","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","volume":"141","author":"JH Lee","year":"2010","unstructured":"Lee, J. H. et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141, 1146\u20131158 https:\/\/doi.org\/10.1016\/j.cell.2010.05.008 (2010).","journal-title":"Cell"},{"key":"1262_CR198","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1111\/ejn.12169","volume":"37","author":"DM Wolfe","year":"2013","unstructured":"Wolfe, D. M. et al. Autophagy failure in Alzheimer\u2019s disease and the role of defective lysosomal acidification. Eur. J. Neurosci. 37, 1949\u20131961 https:\/\/doi.org\/10.1111\/ejn.12169 (2013).","journal-title":"Eur. J. Neurosci."},{"key":"1262_CR199","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuroscience.2014.01.001","volume":"263","author":"EE Coffey","year":"2014","unstructured":"Coffey, E. E., Beckel, J. M., Laties, A. M. & Mitchell, C. H. Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer\u2019s disease-linked presenilin 1 A246E mutation can be reversed with cAMP. Neuroscience 263, 111\u2013124 https:\/\/doi.org\/10.1016\/j.neuroscience.2014.01.001 (2014).","journal-title":"Neuroscience"},{"key":"1262_CR200","doi-asserted-by":"publisher","first-page":"8633","DOI":"10.1523\/JNEUROSCI.0556-12.2012","volume":"32","author":"X Zhang","year":"2012","unstructured":"Zhang, X. et al. A role for presenilins in autophagy revisited: normal acidification of lysosomes in cells lacking PSEN1 and PSEN2. J. Neurosci. 32, 8633\u20138648 https:\/\/doi.org\/10.1523\/JNEUROSCI.0556-12.2012 (2012).","journal-title":"J. Neurosci."},{"key":"1262_CR201","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0945-7","volume":"9","author":"CM Chong","year":"2018","unstructured":"Chong, C. M. et al. Presenilin 1 deficiency suppresses autophagy in human neural stem cells through reducing \u03b3-secretase-independent ERK\/CREB signaling. Cell Death Dis. 9, 879 https:\/\/doi.org\/10.1038\/s41419-018-0945-7 (2018).","journal-title":"Cell Death Dis."},{"key":"1262_CR202","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.celrep.2015.07.050","volume":"12","author":"JH Lee","year":"2015","unstructured":"Lee, J. H. et al. Presenilin 1 maintains lysosomal Ca2+ homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification. Cell Rep. 12, 1430\u20131444 https:\/\/doi.org\/10.1016\/j.celrep.2015.07.050 (2015).","journal-title":"Cell Rep."},{"key":"1262_CR203","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1080\/15548627.2019.1596489","volume":"15","author":"C Fedeli","year":"2019","unstructured":"Fedeli, C., Filadi, R., Rossi, A., Mammucari, C. & Pizzo, P. PSEN2 (presenilin 2) mutants linked to familial Alzheimer disease impair autophagy by altering Ca2+ homeostasis. Autophagy 15, 2044\u20132062 https:\/\/doi.org\/10.1080\/15548627.2019.1596489 (2019).","journal-title":"Autophagy"},{"key":"1262_CR204","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2211999119","volume":"119","author":"S Mustaly-Kalimi","year":"2022","unstructured":"Mustaly-Kalimi, S. et al. Protein mishandling and impaired lysosomal proteolysis generated through calcium dysregulation in Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 119, e2211999119 https:\/\/doi.org\/10.1073\/pnas.2211999119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR205","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261, 921\u2013923 https:\/\/doi.org\/10.1126\/science.8346443 (1993).","journal-title":"Science"},{"key":"1262_CR206","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1001\/jamaneurol.2023.3599","volume":"80","author":"ME Belloy","year":"2023","unstructured":"Belloy, M. E. et al. APOE genotype and Alzheimer disease risk across age, sex, and population ancestry. JAMA Neurol. 80, 1284\u20131294 https:\/\/doi.org\/10.1001\/jamaneurol.2023.3599 (2023).","journal-title":"JAMA Neurol."},{"key":"1262_CR207","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-024-00988-2","volume":"20","author":"RJ Jackson","year":"2024","unstructured":"Jackson, R. J., Hyman, B. T. & Serrano-Pozo, A. Multifaceted roles of APOE in Alzheimer disease. Nat. Rev. Neurol. 20, 457\u2013474 https:\/\/doi.org\/10.1038\/s41582-024-00988-2 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"1262_CR208","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14279-8","volume":"11","author":"EM Reiman","year":"2020","unstructured":"Reiman, E. M. et al. Exceptionally low likelihood of Alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat. Commun. 11, 667 https:\/\/doi.org\/10.1038\/s41467-019-14279-8 (2020).","journal-title":"Nat. Commun."},{"key":"1262_CR209","doi-asserted-by":"publisher","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","volume":"91","author":"DW Dickson","year":"2018","unstructured":"Dickson, D. W. et al. APOE \u03b54 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology 91, e1182\u2013e1195 https:\/\/doi.org\/10.1212\/WNL.0000000000006212 (2018).","journal-title":"Neurology"},{"key":"1262_CR210","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S1474-4422(18)30251-5","volume":"17","author":"HS Yang","year":"2018","unstructured":"Yang, H. S. et al. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE \u03b54 haplotype status: a community-based cohort study. Lancet Neurol. 17, 773\u2013781 https:\/\/doi.org\/10.1016\/S1474-4422(18)30251-5 (2018).","journal-title":"Lancet Neurol."},{"key":"1262_CR211","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/brain\/awy146","volume":"141","author":"JL Robinson","year":"2018","unstructured":"Robinson, J. L. et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 141, 2181\u20132193 https:\/\/doi.org\/10.1093\/brain\/awy146 (2018).","journal-title":"Brain"},{"key":"1262_CR212","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","volume":"25","author":"J Blumenfeld","year":"2024","unstructured":"Blumenfeld, J., Yip, O., Kim, M. J. & Huang, Y. Cell type-specific roles of APOE4 in Alzheimer disease. Nat. Rev. Neurosci. 25, 91\u2013110 https:\/\/doi.org\/10.1038\/s41583-023-00776-9 (2024).","journal-title":"Nat. Rev. Neurosci."},{"key":"1262_CR213","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113183","volume":"42,","author":"H Lee","year":"2023","unstructured":"Lee, H. et al. ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes. Cell Rep. 42, 113183 https:\/\/doi.org\/10.1016\/j.celrep.2023.113183 (2023).","journal-title":"Cell Rep."},{"key":"1262_CR214","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97117-6","volume":"11","author":"HY Sohn","year":"2021","unstructured":"Sohn, H. Y. et al. ApoE4 attenuates autophagy via FoxO3a repression in the brain. Sci. Rep. 11, 17604 https:\/\/doi.org\/10.1038\/s41598-021-97117-6 (2021).","journal-title":"Sci. Rep."},{"key":"1262_CR215","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3233\/JAD-151101","volume":"51","author":"S Simonovitch","year":"2016","unstructured":"Simonovitch, S. et al. Impaired autophagy in APOE4 astrocytes. J. Alzheimers Dis. 51, 915\u2013927 https:\/\/doi.org\/10.3233\/JAD-151101 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"1262_CR216","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jalz.2017.07.754","volume":"14","author":"PA Parcon","year":"2018","unstructured":"Parcon, P. A. et al. Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs. Alzheimers Dement. 14, 230\u2013242 https:\/\/doi.org\/10.1016\/j.jalz.2017.07.754 (2018).","journal-title":"Alzheimers Dement."},{"key":"1262_CR217","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1080\/15548627.2025.2576613","volume":"21","author":"EK Krogsaeter","year":"2025","unstructured":"Krogsaeter, E. K. et al. Lysosomal proteomics reveals mechanisms of neuronal APOE4-associated lysosomal dysfunction. Autophagy 21, 3240\u20133265 https:\/\/doi.org\/10.1080\/15548627.2025.2576613 (2025).","journal-title":"Autophagy"},{"key":"1262_CR218","doi-asserted-by":"publisher","first-page":"E6640","DOI":"10.1073\/pnas.1801612115","volume":"115","author":"H Prasad","year":"2018","unstructured":"Prasad, H. & Rao, R. Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH. Proc. Natl Acad. Sci. USA 115, E6640\u2013E6649 https:\/\/doi.org\/10.1073\/pnas.1801612115 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR219","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cell.2024.10.027","volume":"188","author":"JL Guo","year":"2025","unstructured":"Guo, J. L. et al. Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes. Cell 188, 187\u2013206.e26 https:\/\/doi.org\/10.1016\/j.cell.2024.10.027 (2025).","journal-title":"Cell"},{"key":"1262_CR220","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng, F. & Edison, P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat. Rev. Neurol. 17, 157\u2013172 https:\/\/doi.org\/10.1038\/s41582-020-00435-y (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"1262_CR221","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290.e17 https:\/\/doi.org\/10.1016\/j.cell.2017.05.018 (2017).","journal-title":"Cell"},{"key":"1262_CR222","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N. Engl. J. Med. 368, 107\u2013116 https:\/\/doi.org\/10.1056\/NEJMoa1211103 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1262_CR223","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro, R. et al. TREM2 variants in Alzheimer\u2019s disease. N. Engl. J. Med. 368, 117\u2013127 https:\/\/doi.org\/10.1056\/NEJMoa1211851 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1262_CR224","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1038\/s41591-025-03816-2","volume":"31","author":"M Colonna","year":"2025","unstructured":"Colonna, M. & Holtzman, D. M. Rethinking TREM2 as a target for Alzheimer\u2019s disease after the INVOKE-2 trial failure. Nat. Med. 31, 3217\u20133218 https:\/\/doi.org\/10.1038\/s41591-025-03816-2 (2025).","journal-title":"Nat. Med."},{"key":"1262_CR225","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00042","volume":"14","author":"YA Abramzon","year":"2020","unstructured":"Abramzon, Y. A., Fratta, P., Traynor, B. J. & Chia, R. The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Front. Neurosci. 14, 42 https:\/\/doi.org\/10.3389\/fnins.2020.00042 (2020).","journal-title":"Front. Neurosci."},{"key":"1262_CR226","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky, K. et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456\u20132477 https:\/\/doi.org\/10.1093\/brain\/awr179 (2011).","journal-title":"Brain"},{"key":"1262_CR227","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini, M. L. et al. Classification of primary progressive aphasia and its variants. Neurology 76, 1006\u20131014 https:\/\/doi.org\/10.1212\/WNL.0b013e31821103e6 (2011).","journal-title":"Neurology"},{"key":"1262_CR228","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1212\/CON.0000000000000911","volume":"26","author":"C Quinn","year":"2020","unstructured":"Quinn, C. & Elman, L. Amyotrophic lateral sclerosis and other motor neuron diseases. Continuum 26, 1323\u20131347 https:\/\/doi.org\/10.1212\/CON.0000000000000911 (2020).","journal-title":"Continuum"},{"key":"1262_CR229","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1212\/01.wnl.0000172911.39167.b6","volume":"65","author":"GM Ringholz","year":"2005","unstructured":"Ringholz, G. M. et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65, 586\u2013590 https:\/\/doi.org\/10.1212\/01.wnl.0000172911.39167.b6 (2005).","journal-title":"Neurology"},{"key":"1262_CR230","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00401-015-1475-3","volume":"130","author":"EL Clayton","year":"2015","unstructured":"Clayton, E. L. et al. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology. Acta Neuropathol. 130, 511\u2013523 https:\/\/doi.org\/10.1007\/s00401-015-1475-3 (2015).","journal-title":"Acta Neuropathol."},{"key":"1262_CR231","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai, T. et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602\u2013611 https:\/\/doi.org\/10.1016\/j.bbrc.2006.10.093 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1262_CR232","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00401-007-0236-3","volume":"114","author":"J Snowden","year":"2007","unstructured":"Snowden, J., Neary, D. & Mann, D. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol. 114, 31\u201338 https:\/\/doi.org\/10.1007\/s00401-007-0236-3 (2007).","journal-title":"Acta Neuropathol."},{"key":"1262_CR233","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00401-010-0698-6","volume":"120","author":"H Urwin","year":"2010","unstructured":"Urwin, H. et al. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 120, 33\u201341 https:\/\/doi.org\/10.1007\/s00401-010-0698-6 (2010).","journal-title":"Acta Neuropathol."},{"key":"1262_CR234","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.brainres.2011.12.010","volume":"1462","author":"IR Mackenzie","year":"2012","unstructured":"Mackenzie, I. R. & Neumann, M. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis. Brain Res. 1462, 40\u201343 https:\/\/doi.org\/10.1016\/j.brainres.2011.12.010 (2012).","journal-title":"Brain Res."},{"key":"1262_CR235","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/archneurol.2008.558","volume":"66","author":"F Geser","year":"2009","unstructured":"Geser, F. et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch. Neurol. 66, 180\u2013189 https:\/\/doi.org\/10.1001\/archneurol.2008.558 (2009).","journal-title":"Arch. Neurol."},{"key":"1262_CR236","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/ana.22051","volume":"67","author":"HX Deng","year":"2010","unstructured":"Deng, H. X. et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann. Neurol. 67, 739\u2013748 https:\/\/doi.org\/10.1002\/ana.22051 (2010).","journal-title":"Ann. Neurol."},{"key":"1262_CR237","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.tins.2023.09.004","volume":"46","author":"TW Todd","year":"2023","unstructured":"Todd, T. W., Shao, W., Zhang, Y. J. & Petrucelli, L. The endolysosomal pathway and ALS\/FTD. Trends Neurosci. 46, 1025\u20131041 https:\/\/doi.org\/10.1016\/j.tins.2023.09.004 (2023).","journal-title":"Trends Neurosci."},{"key":"1262_CR238","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05016","volume":"442","author":"M Baker","year":"2006","unstructured":"Baker, M. et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442, 916\u2013919 https:\/\/doi.org\/10.1038\/nature05016 (2006).","journal-title":"Nature"},{"key":"1262_CR239","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130\u2013133 https:\/\/doi.org\/10.1126\/science.1134108 (2006).","journal-title":"Science"},{"key":"1262_CR240","doi-asserted-by":"publisher","first-page":"200.e1","DOI":"10.1016\/j.neurobiolaging.2016.02.019","volume":"41","author":"MR Almeida","year":"2016","unstructured":"Almeida, M. R. et al. Portuguese family with the co-occurrence of frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis phenotypes due to progranulin gene mutation. Neurobiol. Aging 41, 200.e1\u2013200.e5 https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.02.019 (2016).","journal-title":"Neurobiol. Aging"},{"key":"1262_CR241","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/brain\/awz377","volume":"143","author":"V Huin","year":"2020","unstructured":"Huin, V. et al. Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms. Brain 143, 303\u2013319 https:\/\/doi.org\/10.1093\/brain\/awz377 (2020).","journal-title":"Brain"},{"key":"1262_CR242","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.celrep.2017.08.056","volume":"20","author":"BM Evers","year":"2017","unstructured":"Evers, B. M. et al. Lipidomic and transcriptomic basis of lysosomal dysfunction in progranulin deficiency. Cell Rep. 20, 2565\u20132574 https:\/\/doi.org\/10.1016\/j.celrep.2017.08.056 (2017).","journal-title":"Cell Rep."},{"key":"1262_CR243","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/hmg\/ddx011","volume":"26","author":"Y Tanaka","year":"2017","unstructured":"Tanaka, Y. et al. Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes. Hum. Mol. Genet. 26, 969\u2013988 https:\/\/doi.org\/10.1093\/hmg\/ddx011 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"1262_CR244","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/hmg\/ddz229","volume":"29","author":"C Valdez","year":"2020","unstructured":"Valdez, C., Ysselstein, D., Young, T. J., Zheng, J. & Krainc, D. Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity. Hum. Mol. Genet. 29, 716\u2013726 https:\/\/doi.org\/10.1093\/hmg\/ddz229 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"1262_CR245","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jmb.2019.01.027","volume":"431","author":"VJ Butler","year":"2019","unstructured":"Butler, V. J. et al. Progranulin stimulates the in vitro maturation of pro-cathepsin D at acidic pH. J. Mol. Biol. 431, 1038\u20131047 https:\/\/doi.org\/10.1016\/j.jmb.2019.01.027 (2019).","journal-title":"J. Mol. Biol."},{"key":"1262_CR246","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00401-017-1719-5","volume":"134","author":"X Zhou","year":"2017","unstructured":"Zhou, X. et al. Regulation of cathepsin D activity by the FTLD protein progranulin. Acta Neuropathol. 134, 151\u2013153 https:\/\/doi.org\/10.1007\/s00401-017-1719-5 (2017).","journal-title":"Acta Neuropathol."},{"key":"1262_CR247","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0100-17.2017","volume":"4","author":"CJ Holler","year":"2017","unstructured":"Holler, C. J., Taylor, G., Deng, Q. & Kukar, T. Intracellular proteolysis of progranulin generates stable, lysosomal granulins that are haploinsufficient in patients with frontotemporal dementia caused by GRN mutations. eNeuro 4, ENEURO.0100-17.2017 https:\/\/doi.org\/10.1523\/ENEURO.0100-17.2017 (2017).","journal-title":"eNeuro"},{"key":"1262_CR248","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0205-9","volume":"12","author":"X Zhou","year":"2017","unstructured":"Zhou, X. et al. Lysosomal processing of progranulin. Mol. Neurodegener. 12, 62 https:\/\/doi.org\/10.1186\/s13024-017-0205-9 (2017).","journal-title":"Mol. Neurodegener."},{"key":"1262_CR249","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab310","volume":"4","author":"H Du","year":"2022","unstructured":"Du, H., Zhou, X., Feng, T. & Hu, F. Regulation of lysosomal trafficking of progranulin by sortilin and prosaposin. Brain Commun. 4, fcab310 https:\/\/doi.org\/10.1093\/braincomms\/fcab310 (2022).","journal-title":"Brain Commun."},{"key":"1262_CR250","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1083\/jcb.201502029","volume":"210","author":"X Zhou","year":"2015","unstructured":"Zhou, X. et al. Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin. J. Cell Biol. 210, 991\u20131002 https:\/\/doi.org\/10.1083\/jcb.201502029 (2015).","journal-title":"J. Cell Biol."},{"key":"1262_CR251","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0022-2275(20)40540-1","volume":"33","author":"Y Kishimoto","year":"1992","unstructured":"Kishimoto, Y., Hiraiwa, M. & O\u2019Brien, J. S. Saposins: structure, function, distribution, and molecular genetics. J. Lipid Res. 33, 1255\u20131267 (1992).","journal-title":"J. Lipid Res."},{"key":"1262_CR252","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ymgme.2004.10.004","volume":"84","author":"R Spiegel","year":"2005","unstructured":"Spiegel, R. et al. A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans. Mol. Genet. Metab. 84, 160\u2013166 https:\/\/doi.org\/10.1016\/j.ymgme.2004.10.004 (2005).","journal-title":"Mol. Genet. Metab."},{"key":"1262_CR253","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1073\/pnas.87.7.2541","volume":"87","author":"KA Kretz","year":"1990","unstructured":"Kretz, K. A. et al. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect. Proc. Natl Acad. Sci. USA 87, 2541\u20132544 https:\/\/doi.org\/10.1073\/pnas.87.7.2541 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR254","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1399-0004.2007.00899.x","volume":"72","author":"A Tylki-Szymanska","year":"2007","unstructured":"Tylki-Szymanska, A. et al. Non-neuronopathic Gaucher disease due to saposin C deficiency. Clin. Genet. 72, 538\u2013542 https:\/\/doi.org\/10.1111\/j.1399-0004.2007.00899.x (2007).","journal-title":"Clin. Genet."},{"key":"1262_CR255","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1093\/hmg\/ddx162","volume":"26","author":"S Beel","year":"2017","unstructured":"Beel, S. et al. Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo. Hum. Mol. Genet. 26, 2850\u20132863 https:\/\/doi.org\/10.1093\/hmg\/ddx162 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"1262_CR256","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1093\/hmg\/ddx364","volume":"26","author":"C Valdez","year":"2017","unstructured":"Valdez, C. et al. Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients. Hum. Mol. Genet. 26, 4861\u20134872 https:\/\/doi.org\/10.1093\/hmg\/ddx364 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"1262_CR257","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0872-6","volume":"7","author":"AE Arrant","year":"2019","unstructured":"Arrant, A. E. et al. Impaired \u03b2-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations. Acta Neuropathol. Commun. 7, 218 https:\/\/doi.org\/10.1186\/s40478-019-0872-6 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"1262_CR258","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1021\/acs.biochem.9b00275","volume":"58","author":"VJ Butler","year":"2019","unstructured":"Butler, V. J. et al. Multi-granulin domain peptides bind to pro-cathepsin D and stimulate its enzymatic activity more effectively than progranulin in vitro. Biochemistry 58, 2670\u20132674 https:\/\/doi.org\/10.1021\/acs.biochem.9b00275 (2019).","journal-title":"Biochemistry"},{"key":"1262_CR259","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/brain\/awl107","volume":"129","author":"E Siintola","year":"2006","unstructured":"Siintola, E. et al. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 129, 1438\u20131445 https:\/\/doi.org\/10.1093\/brain\/awl107 (2006).","journal-title":"Brain"},{"key":"1262_CR260","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0281-5","volume":"13","author":"JK Gotzl","year":"2018","unstructured":"Gotzl, J. K. et al. Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice. Mol. Neurodegener. 13, 48 https:\/\/doi.org\/10.1186\/s13024-018-0281-5 (2018).","journal-title":"Mol. Neurodegener."},{"key":"1262_CR261","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/S1474-4422(18)30126-1","volume":"17","author":"C Pottier","year":"2018","unstructured":"Pottier, C. et al. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol. 17, 548\u2013558 https:\/\/doi.org\/10.1016\/S1474-4422(18)30126-1 (2018).","journal-title":"Lancet Neurol."},{"key":"1262_CR262","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/ng.536","volume":"42","author":"VM Van Deerlin","year":"2010","unstructured":"Van Deerlin, V. M. et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet. 42, 234\u2013239 https:\/\/doi.org\/10.1038\/ng.536 (2010).","journal-title":"Nat. Genet."},{"key":"1262_CR263","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1160248","volume":"14","author":"J Perneel","year":"2023","unstructured":"Perneel, J., Manoochehri, M., Huey, E. D., Rademakers, R. & Goldman, J. Case report: TMEM106B haplotype alters penetrance of GRN mutation in frontotemporal dementia family. Front. Neurol. 14, 1160248 https:\/\/doi.org\/10.3389\/fneur.2023.1160248 (2023).","journal-title":"Front. Neurol."},{"key":"1262_CR264","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.mcn.2014.07.006","volume":"61","author":"M Stagi","year":"2014","unstructured":"Stagi, M., Klein, Z. A., Gould, T. J., Bewersdorf, J. & Strittmatter, S. M. Lysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106B. Mol. Cell Neurosci. 61, 226\u2013240 https:\/\/doi.org\/10.1016\/j.mcn.2014.07.006 (2014).","journal-title":"Mol. Cell Neurosci."},{"key":"1262_CR265","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1016\/j.celrep.2020.02.060","volume":"30","author":"P Luningschror","year":"2020","unstructured":"Luningschror, P. et al. The FTLD risk factor TMEM106B regulates the transport of lysosomes at the axon initial segment of motoneurons. Cell Rep. 30, 3506\u20133519.e6 https:\/\/doi.org\/10.1016\/j.celrep.2020.02.060 (2020).","journal-title":"Cell Rep."},{"key":"1262_CR266","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00644-1","volume":"18","author":"HS Jiao","year":"2023","unstructured":"Jiao, H. S., Yuan, P. & Yu, J. T. TMEM106B aggregation in neurodegenerative diseases: linking genetics to function. Mol. Neurodegener. 18, 54 https:\/\/doi.org\/10.1186\/s13024-023-00644-1 (2023).","journal-title":"Mol. Neurodegener."},{"key":"1262_CR267","doi-asserted-by":"publisher","first-page":"11213","DOI":"10.1523\/JNEUROSCI.0521-12.2012","volume":"32","author":"AS Chen-Plotkin","year":"2012","unstructured":"Chen-Plotkin, A. S. et al. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132\/212 cluster and affects progranulin pathways. J. Neurosci. 32, 11213\u201311227 https:\/\/doi.org\/10.1523\/JNEUROSCI.0521-12.2012 (2012).","journal-title":"J. Neurosci."},{"key":"1262_CR268","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1093\/hmg\/ddw127","volume":"25","author":"JI Busch","year":"2016","unstructured":"Busch, J. I. et al. Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes. Hum. Mol. Genet. 25, 2681\u20132697 https:\/\/doi.org\/10.1093\/hmg\/ddw127 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"1262_CR269","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/hmg\/dds475","volume":"22","author":"OA Brady","year":"2013","unstructured":"Brady, O. A., Zheng, Y., Murphy, K., Huang, M. & Hu, F. The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function. Hum. Mol. Genet. 22, 685\u2013695 https:\/\/doi.org\/10.1093\/hmg\/dds475 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"1262_CR270","doi-asserted-by":"publisher","first-page":"19355","DOI":"10.1074\/jbc.M112.365098","volume":"287","author":"CM Lang","year":"2012","unstructured":"Lang, C. M. et al. Membrane orientation and subcellular localization of transmembrane protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration. J. Biol. Chem. 287, 19355\u201319365 https:\/\/doi.org\/10.1074\/jbc.M112.365098 (2012).","journal-title":"J. Biol. Chem."},{"key":"1262_CR271","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/jnc.12329","volume":"126","author":"AM Nicholson","year":"2013","unstructured":"Nicholson, A. M. et al. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia. J. Neurochem. 126, 781\u2013791 https:\/\/doi.org\/10.1111\/jnc.12329 (2013).","journal-title":"J. Neurochem."},{"key":"1262_CR272","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050197","volume":"21","author":"X Zhou","year":"2020","unstructured":"Zhou, X. et al. Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice. EMBO Rep. 21, e50197 https:\/\/doi.org\/10.15252\/embr.202050197 (2020).","journal-title":"EMBO Rep."},{"key":"1262_CR273","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050219","volume":"21","author":"T Feng","year":"2020","unstructured":"Feng, T. et al. Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice. EMBO Rep. 21, e50219 https:\/\/doi.org\/10.15252\/embr.202050219 (2020).","journal-title":"EMBO Rep."},{"key":"1262_CR274","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050241","volume":"21","author":"G Werner","year":"2020","unstructured":"Werner, G. et al. Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice. EMBO Rep. 21, e50241 https:\/\/doi.org\/10.15252\/embr.202050241 (2020).","journal-title":"EMBO Rep."},{"key":"1262_CR275","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41586-022-04670-9","volume":"605","author":"YX Jiang","year":"2022","unstructured":"Jiang, Y. X. et al. Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43. Nature 605, 304\u2013309 https:\/\/doi.org\/10.1038\/s41586-022-04670-9 (2022).","journal-title":"Nature"},{"key":"1262_CR276","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.cell.2022.02.026","volume":"185","author":"A Chang","year":"2022","unstructured":"Chang, A. et al. Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases. Cell 185, 1346\u20131355.e15 https:\/\/doi.org\/10.1016\/j.cell.2022.02.026 (2022).","journal-title":"Cell"},{"key":"1262_CR277","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-022-04650-z","volume":"605","author":"M Schweighauser","year":"2022","unstructured":"Schweighauser, M. et al. Age-dependent formation of TMEM106B amyloid filaments in human brains. Nature 605, 310\u2013314 https:\/\/doi.org\/10.1038\/s41586-022-04650-z (2022).","journal-title":"Nature"},{"key":"1262_CR278","doi-asserted-by":"publisher","unstructured":"Replogle, J. M. et al. Neurodegeneration risk variants promote lysosomal TMEM106B fibril accumulation. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2026.03.26.714634 (2026).","DOI":"10.64898\/2026.03.26.714634"},{"key":"1262_CR279","doi-asserted-by":"publisher","unstructured":"Zeng, Y. et al. Granulin loss and TMEM106B risk converge on lysosomal C-terminal fragment pathology in frontotemporal dementia. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2026.03.25.713523 (2026).","DOI":"10.64898\/2026.03.25.713523"},{"key":"1262_CR280","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adj7308","volume":"16","author":"M Reich","year":"2024","unstructured":"Reich, M. et al. Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration. Sci. Transl. Med. 16, eadj7308 https:\/\/doi.org\/10.1126\/scitranslmed.adj7308 (2024).","journal-title":"Sci. Transl. Med."},{"key":"1262_CR281","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1016\/j.cell.2021.08.002","volume":"184","author":"T Logan","year":"2021","unstructured":"Logan, T. et al. Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic. Cell 184, 4651\u20134668.e25 https:\/\/doi.org\/10.1016\/j.cell.2021.08.002 (2021).","journal-title":"Cell"},{"key":"1262_CR282","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41591-024-02973-0","volume":"30","author":"J Sevigny","year":"2024","unstructured":"Sevigny, J. et al. Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1\/2 trial interim results. Nat. Med. 30, 1406\u20131415 https:\/\/doi.org\/10.1038\/s41591-024-02973-0 (2024).","journal-title":"Nat. Med."},{"key":"1262_CR283","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12452","volume":"10","author":"M Ward","year":"2024","unstructured":"Ward, M. et al. Phase 1 study of latozinemab in progranulin-associated frontotemporal dementia. Alzheimers Dement. 10, e12452 https:\/\/doi.org\/10.1002\/trc2.12452 (2024).","journal-title":"Alzheimers Dement."},{"key":"1262_CR284","doi-asserted-by":"publisher","DOI":"10.3390\/neurosci6040114","volume":"6","author":"P Bartoshyk","year":"2025","unstructured":"Bartoshyk, P. & O\u2019Caoimh, R. Update on disease-modifying pharmacological treatments for frontotemporal dementia (FTD): a scoping review of registered trials. NeuroSci 6, 114 https:\/\/doi.org\/10.3390\/neurosci6040114 (2025).","journal-title":"NeuroSci"},{"key":"1262_CR285","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton, A. E. et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257\u2013268 https:\/\/doi.org\/10.1016\/j.neuron.2011.09.010 (2011).","journal-title":"Neuron"},{"key":"1262_CR286","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1126\/science.1232927","volume":"339","author":"K Mori","year":"2013","unstructured":"Mori, K. et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS. Science 339, 1335\u20131338 https:\/\/doi.org\/10.1126\/science.1232927 (2013).","journal-title":"Science"},{"key":"1262_CR287","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","volume":"77","author":"PE Ash","year":"2013","unstructured":"Ash, P. E. et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS. Neuron 77, 639\u2013646 https:\/\/doi.org\/10.1016\/j.neuron.2013.02.004 (2013).","journal-title":"Neuron"},{"key":"1262_CR288","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00589","volume":"12","author":"A Viode","year":"2018","unstructured":"Viode, A. et al. New antibody-free mass spectrometry-based quantification reveals that C9ORF72 long protein isoform is reduced in the frontal cortex of hexanucleotide-repeat expansion carriers. Front. Neurosci. 12, 589 https:\/\/doi.org\/10.3389\/fnins.2018.00589 (2018).","journal-title":"Front. Neurosci."},{"key":"1262_CR289","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1080\/15548627.2019.1703353","volume":"16","author":"Q Shao","year":"2020","unstructured":"Shao, Q. et al. C9orf72 and smcr8 mutant mice reveal MTORC1 activation due to impaired lysosomal degradation and exocytosis. Autophagy 16, 1635\u20131650 https:\/\/doi.org\/10.1080\/15548627.2019.1703353 (2020).","journal-title":"Autophagy"},{"key":"1262_CR290","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1091\/mbc.E16-01-0003","volume":"27","author":"J Amick","year":"2016","unstructured":"Amick, J., Roczniak-Ferguson, A. & Ferguson, S. M. C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling. Mol. Biol. Cell 27, 3040\u20133051 https:\/\/doi.org\/10.1091\/mbc.E16-01-0003 (2016).","journal-title":"Mol. Biol. Cell"},{"key":"1262_CR291","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.15252\/embj.201593350","volume":"35","author":"C Sellier","year":"2016","unstructured":"Sellier, C. et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 35, 1276\u20131297 https:\/\/doi.org\/10.15252\/embj.201593350 (2016).","journal-title":"EMBO J."},{"key":"1262_CR292","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100574","volume":"39","author":"M Boivin","year":"2020","unstructured":"Boivin, M. et al. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. EMBO J. 39, e100574 https:\/\/doi.org\/10.15252\/embj.2018100574 (2020).","journal-title":"EMBO J."},{"key":"1262_CR293","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-023-01648-0","volume":"11","author":"J Beckers","year":"2023","unstructured":"Beckers, J. et al. A toxic gain-of-function mechanism in C9orf72 ALS impairs the autophagy-lysosome pathway in neurons. Acta Neuropathol. Commun. 11, 151 https:\/\/doi.org\/10.1186\/s40478-023-01648-0 (2023).","journal-title":"Acta Neuropathol. Commun."},{"key":"1262_CR294","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201906076","volume":"219","author":"J Amick","year":"2020","unstructured":"Amick, J., Tharkeshwar, A. K., Talaia, G. & Ferguson, S. M. PQLC2 recruits the C9orf72 complex to lysosomes in response to cationic amino acid starvation. J. Cell Biol. 219, e201906076 https:\/\/doi.org\/10.1083\/jcb.201906076 (2020).","journal-title":"J. Cell Biol."},{"key":"1262_CR295","doi-asserted-by":"publisher","first-page":"9876","DOI":"10.1073\/pnas.2002110117","volume":"117","author":"D Tang","year":"2020","unstructured":"Tang, D. et al. Cryo-EM structure of C9ORF72\u2013SMCR8\u2013WDR41 reveals the role as a GAP for Rab8a and Rab11a. Proc. Natl Acad. Sci. USA 117, 9876\u20139883 https:\/\/doi.org\/10.1073\/pnas.2002110117 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR296","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1601167","volume":"2","author":"M Yang","year":"2016","unstructured":"Yang, M. et al. A C9ORF72\/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci. Adv. 2, e1601167 https:\/\/doi.org\/10.1126\/sciadv.1601167 (2016).","journal-title":"Sci. Adv."},{"key":"1262_CR297","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42003-0","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. C9orf72-catalyzed GTP loading of Rab39A enables HOPS-mediated membrane tethering and fusion in mammalian autophagy. Nat. Commun. 14, 6360 https:\/\/doi.org\/10.1038\/s41467-023-42003-0 (2023).","journal-title":"Nat. Commun."},{"key":"1262_CR298","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006443","volume":"12","author":"J Ugolino","year":"2016","unstructured":"Ugolino, J. et al. Loss of C9orf72 enhances autophagic activity via deregulated mTOR and TFEB signaling. PLoS Genet. 12, e1006443 https:\/\/doi.org\/10.1371\/journal.pgen.1006443 (2016).","journal-title":"PLoS Genet."},{"key":"1262_CR299","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13126","volume":"19","author":"M Wang","year":"2020","unstructured":"Wang, M. et al. C9orf72 associates with inactive Rag GTPases and regulates mTORC1-mediated autophagosomal and lysosomal biogenesis. Aging Cell 19, e13126 https:\/\/doi.org\/10.1111\/acel.13126 (2020).","journal-title":"Aging Cell"},{"key":"1262_CR300","doi-asserted-by":"publisher","DOI":"10.1038\/srep23204","volume":"6","author":"A Atanasio","year":"2016","unstructured":"Atanasio, A. et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci. Rep. 6, 23204 https:\/\/doi.org\/10.1038\/srep23204 (2016).","journal-title":"Sci. Rep."},{"key":"1262_CR301","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/j.neuron.2021.05.020","volume":"109","author":"D Lall","year":"2021","unstructured":"Lall, D. et al. C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation. Neuron 109, 2275\u20132291.e8 https:\/\/doi.org\/10.1016\/j.neuron.2021.05.020 (2021).","journal-title":"Neuron"},{"key":"1262_CR302","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41586-020-2288-7","volume":"582","author":"A Burberry","year":"2020","unstructured":"Burberry, A. et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature 582, 89\u201394 https:\/\/doi.org\/10.1038\/s41586-020-2288-7 (2020).","journal-title":"Nature"},{"key":"1262_CR303","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-020-2625-x","volume":"585","author":"ME McCauley","year":"2020","unstructured":"McCauley, M. E. et al. C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature 585, 96\u2013101 https:\/\/doi.org\/10.1038\/s41586-020-2625-x (2020).","journal-title":"Nature"},{"key":"1262_CR304","doi-asserted-by":"publisher","DOI":"10.1002\/glia.70084","volume":"74","author":"Y Gao","year":"2025","unstructured":"Gao, Y. et al. Altered inflammatory signature in a C9ORF72-ALS iPSC-derived motor neuron and microglia coculture model. Glia 74, e70084 https:\/\/doi.org\/10.1002\/glia.70084 (2025).","journal-title":"Glia"},{"key":"1262_CR305","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1038\/s41593-025-02075-1","volume":"28","author":"P Masrori","year":"2025","unstructured":"Masrori, P. et al. C9orf72 hexanucleotide repeat expansions impair microglial response in ALS. Nat. Neurosci. 28, 2217\u20132230 https:\/\/doi.org\/10.1038\/s41593-025-02075-1 (2025).","journal-title":"Nat. Neurosci."},{"key":"1262_CR306","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/ng1609","volume":"37","author":"G Skibinski","year":"2005","unstructured":"Skibinski, G. et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 37, 806\u2013808 https:\/\/doi.org\/10.1038\/ng1609 (2005).","journal-title":"Nat. Genet."},{"key":"1262_CR307","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009872","volume":"5","author":"LE Cox","year":"2010","unstructured":"Cox, L. E. et al. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS ONE 5, e9872 https:\/\/doi.org\/10.1371\/journal.pone.0009872 (2010).","journal-title":"PLoS ONE"},{"key":"1262_CR308","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41586-025-08950-y","volume":"642","author":"JH Hurley","year":"2025","unstructured":"Hurley, J. H., Coyne, A. N., Miaczynska, M. & Stenmark, H. The expanding repertoire of ESCRT functions in cell biology and disease. Nature 642, 877\u2013888 https:\/\/doi.org\/10.1038\/s41586-025-08950-y (2025).","journal-title":"Nature"},{"key":"1262_CR309","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar5078","volume":"360","author":"ML Skowyra","year":"2018","unstructured":"Skowyra, M. L., Schlesinger, P. H., Naismith, T. V. & Hanson, P. I. Triggered recruitment of ESCRT machinery promotes endolysosomal repair. Science 360, earr5078 https:\/\/doi.org\/10.1126\/science.aar5078 (2018).","journal-title":"Science"},{"key":"1262_CR310","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1093\/hmg\/ddq100","volume":"19","author":"H Urwin","year":"2010","unstructured":"Urwin, H. et al. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Hum. Mol. Genet. 19, 2228\u20132238 https:\/\/doi.org\/10.1093\/hmg\/ddq100 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"1262_CR311","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/hmg\/ddm309","volume":"17","author":"J van der Zee","year":"2008","unstructured":"van der Zee, J. et al. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum. Mol. Genet. 17, 313\u2013322 https:\/\/doi.org\/10.1093\/hmg\/ddm309 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"1262_CR312","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.cub.2007.07.029","volume":"17","author":"JA Lee","year":"2007","unstructured":"Lee, J. A., Beigneux, A., Ahmad, S. T., Young, S. G. & Gao, F. B. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr. Biol. 17, 1561\u20131567 https:\/\/doi.org\/10.1016\/j.cub.2007.07.029 (2007).","journal-title":"Curr. Biol."},{"key":"1262_CR313","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.devcel.2026.05.014","volume":"61","author":"CM Heffner","year":"2026","unstructured":"Heffner, C. M. et al. The ALS- and FTD-associated proteins annexin A11 and CHMP2B act sequentially in plasma membrane repair. Dev. Cell 61, 1487\u20131503.e7 https:\/\/doi.org\/10.1016\/j.devcel.2026.05.014 (2026).","journal-title":"Dev. Cell"},{"key":"1262_CR314","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/archneurol.2011.250","volume":"68","author":"F Fecto","year":"2011","unstructured":"Fecto, F. et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 68, 1440\u20131446 https:\/\/doi.org\/10.1001\/archneurol.2011.250 (2011).","journal-title":"Arch. Neurol."},{"key":"1262_CR315","doi-asserted-by":"publisher","first-page":"266.e1","DOI":"10.1016\/j.neurobiolaging.2018.06.015","volume":"71","author":"M de Majo","year":"2018","unstructured":"de Majo, M. et al. ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function. Neurobiol. Aging 71, 266.e1\u2013266.e10 https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.06.015 (2018).","journal-title":"Neurobiol. Aging"},{"key":"1262_CR316","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a003913","volume":"5","author":"R Lamb","year":"2019","unstructured":"Lamb, R. et al. A novel TBK1 mutation in a family with diverse frontotemporal dementia spectrum disorders. Cold Spring Harb. Mol. Case Stud. 5, a003913 https:\/\/doi.org\/10.1101\/mcs.a003913 (2019).","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"1262_CR317","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.aaa3650","volume":"347","author":"ET Cirulli","year":"2015","unstructured":"Cirulli, E. T. et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347, 1436\u20131441 https:\/\/doi.org\/10.1126\/science.aaa3650 (2015).","journal-title":"Science"},{"key":"1262_CR318","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","volume":"68","author":"JO Johnson","year":"2010","unstructured":"Johnson, J. O. et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68, 857\u2013864 https:\/\/doi.org\/10.1016\/j.neuron.2010.11.036 (2010).","journal-title":"Neuron"},{"key":"1262_CR319","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng1332","volume":"36","author":"GD Watts","year":"2004","unstructured":"Watts, G. D. et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36, 377\u2013381 https:\/\/doi.org\/10.1038\/ng1332 (2004).","journal-title":"Nat. Genet."},{"key":"1262_CR320","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nature10353","volume":"477","author":"HX Deng","year":"2011","unstructured":"Deng, H. X. et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia. Nature 477, 211\u2013215 https:\/\/doi.org\/10.1038\/nature10353 (2011).","journal-title":"Nature"},{"key":"1262_CR321","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004987","volume":"11","author":"J Lim","year":"2015","unstructured":"Lim, J. et al. Proteotoxic stress induces phosphorylation of p62\/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates. PLoS Genet. 11, e1004987 https:\/\/doi.org\/10.1371\/journal.pgen.1004987 (2015).","journal-title":"PLoS Genet."},{"key":"1262_CR322","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00401-013-1090-0","volume":"125","author":"E Teyssou","year":"2013","unstructured":"Teyssou, E. et al. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol. 125, 511\u2013522 https:\/\/doi.org\/10.1007\/s00401-013-1090-0 (2013).","journal-title":"Acta Neuropathol."},{"key":"1262_CR323","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/15548627.2019.1644076","volume":"16","author":"Z Deng","year":"2020","unstructured":"Deng, Z. et al. ALS-FTLD-linked mutations of SQSTM1\/p62 disrupt selective autophagy and NFE2L2\/NRF2 anti-oxidative stress pathway. Autophagy 16, 917\u2013931 https:\/\/doi.org\/10.1080\/15548627.2019.1644076 (2020).","journal-title":"Autophagy"},{"key":"1262_CR324","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01280-w","volume":"9","author":"FX Blaudin de The","year":"2021","unstructured":"Blaudin de The, F. X. et al. P62 accumulates through neuroanatomical circuits in response to tauopathy propagation. Acta Neuropathol. Commun. 9, 177 https:\/\/doi.org\/10.1186\/s40478-021-01280-w (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"1262_CR325","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12708","volume":"7","author":"F Li","year":"2016","unstructured":"Li, F. et al. Structural insights into the interaction and disease mechanism of neurodegenerative disease-associated optineurin and TBK1 proteins. Nat. Commun. 7, 12708 https:\/\/doi.org\/10.1038\/ncomms12708 (2016).","journal-title":"Nat. Commun."},{"key":"1262_CR326","doi-asserted-by":"publisher","first-page":"E3349","DOI":"10.1073\/pnas.1523810113","volume":"113","author":"AS Moore","year":"2016","unstructured":"Moore, A. S. & Holzbaur, E. L. Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy. Proc. Natl Acad. Sci. USA 113, E3349\u2013E3358 https:\/\/doi.org\/10.1073\/pnas.1523810113 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR327","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1073\/pnas.1523926113","volume":"113","author":"B Richter","year":"2016","unstructured":"Richter, B. et al. Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc. Natl Acad. Sci. USA 113, 4039\u20134044 https:\/\/doi.org\/10.1073\/pnas.1523926113 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR328","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1080\/15548627.2021.1898742","volume":"17","author":"L Wrobel","year":"2021","unstructured":"Wrobel, L., Hill, S. M., Ashkenazi, A. & Rubinsztein, D. C. VCP\/p97 modulates PtdIns3P production and autophagy initiation. Autophagy 17, 1052\u20131053 https:\/\/doi.org\/10.1080\/15548627.2021.1898742 (2021).","journal-title":"Autophagy"},{"key":"1262_CR329","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41589-020-00726-x","volume":"17","author":"SM Hill","year":"2021","unstructured":"Hill, S. M. et al. VCP\/p97 regulates Beclin-1-dependent autophagy initiation. Nat. Chem. Biol. 17, 448\u2013455 https:\/\/doi.org\/10.1038\/s41589-020-00726-x (2021).","journal-title":"Nat. Chem. Biol."},{"key":"1262_CR330","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59556-x","volume":"16","author":"M Korner","year":"2025","unstructured":"Korner, M. et al. p97\/VCP is required for piecemeal autophagy of aggresomes. Nat. Commun. 16, 4243 https:\/\/doi.org\/10.1038\/s41467-025-59556-x (2025).","journal-title":"Nat. Commun."},{"key":"1262_CR331","doi-asserted-by":"publisher","first-page":"135","DOI":"10.15252\/embj.201695148","volume":"36","author":"C Papadopoulos","year":"2017","unstructured":"Papadopoulos, C. et al. VCP\/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy. EMBO J. 36, 135\u2013150 https:\/\/doi.org\/10.15252\/embj.201695148 (2017).","journal-title":"EMBO J."},{"key":"1262_CR332","doi-asserted-by":"publisher","first-page":"15230","DOI":"10.1073\/pnas.1917371117","volume":"117","author":"JJ Wu","year":"2020","unstructured":"Wu, J. J. et al. ALS\/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function. Proc. Natl Acad. Sci. USA 117, 15230\u201315241 https:\/\/doi.org\/10.1073\/pnas.1917371117 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1262_CR333","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1001\/jamaneurol.2025.4946","volume":"83","author":"TM Miller","year":"2026","unstructured":"Miller, T. M. et al. Long-term tofersen in SOD1 amyotrophic lateral sclerosis. JAMA Neurol. 83, 115\u2013125 https:\/\/doi.org\/10.1001\/jamaneurol.2025.4946 (2026).","journal-title":"JAMA Neurol."},{"key":"1262_CR334","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136268","volume":"26","author":"M Cattaneo","year":"2025","unstructured":"Cattaneo, M., Giagnorio, E., Lauria, G. & Marcuzzo, S. Therapeutic approaches for C9ORF72-related ALS: current strategies and future horizons. Int. J. Mol. Sci. 26, 6268 https:\/\/doi.org\/10.3390\/ijms26136268 (2025).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01262-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01262-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01262-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:01:35Z","timestamp":1793192495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01262-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":334,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1262"],"URL":"https:\/\/doi.org\/10.1038\/s41582-026-01262-3","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"12 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.K. is the founder and scientific advisory board chair of Vanqua Bio, serves on the scientific advisory boards of The Silverstein Foundation, Intellia Therapeutics and AcureX Therapeutics, and is a venture partner at OrbiMed. S.M.B. and R.C. declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}